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CHAPTER 1: BACKGROUND INFORMATION 
 
Importance of Carbohydrates 
There are four major classes of macromolecules in biology, DNA, proteins, carbohydrates 
and lipids. Carbohydrates differ from the other classes of biological polymers in two 
important characteristics: they can be highly branched molecules, and many different 
linkage types can connect their monomeric units to one another. This complexity allows 
carbohydrates to present in almost unlimited structure variations. The basic building blocks 
of carbohydrates are monosaccharides. The carbohydrates are a major source of metabolic 
energy, both for plants and for animals that depend on plants for food. Apart from the 
sugars and starches that meet this vital nutrition role, carbohydrates play important role in 
carrying out various biological functions. In all living organisms, the two monosaccharides 
ribose and deoxyribose form part of the structure of nucleic acids DNA and RNA in which 
sugar rings form the backbone to which the bases encoding the genetic information are 
covalently linked. Carbohydrates are also linked to proteins (glycoproteins) and lipids 
(glycolipids) where they play important structural roles and are involved in many cell 
communication and signaling events.  
Glycoproteins (Allen 1992, Kobata 1993, Lee 1994) are fundamental to many important 
biological processes including fertilization, immune defense, viral replication, degradation 
of blood clots, cell growth, cell-cell adhesion, and inflammation (Yaki 1986, Spohr 1988, 
Phillips 1990, Lasky 1992, Miller 1992, Schulze 1992, Varki 1993, Levy 1994, Tulsiani 
1997,). Carbohydrates are linked to proteins either by oxygen or nitrogen and are termed as 
1
O-linked and N-linked glycans respectively. Glycoproteins and glycolipids are major 
components of the outer surface of mammalian cells. Oligosaccharide structures change 
dramatically during development, and it has been shown that specific sets of 
oligosaccharides are expressed at distinct stages of differentiation. Further, alterations in 
cell surface oligosaccharides are associated with various pathological conditions including 
malignant tranformation.  
The role of DNA and proteins in biological events termed as genomics and proteomics 
respectively, have been well studied. But study of the role of carbohydrates in biology is 
just beginning to expand. Glycomics examines how the addition of sugars to proteins 
(glycosylation) affects biological systems. In many cases it is not the protein itself that is 
relevant to disease status, but the modification associated with that protein. Glycosylation 
is one of the major posttranslational modification events affecting proteins and has been 
implicated in various biological events such as cancer, congenital disorders, infections, 
autoimmune diseases and signaling.  
The interactions between saccharides and their receptors are of vital importance in many 
normal cellular mechanisms. These interactions are being recognized as important in a 
range of disease processes, including, for example, infections by bacteria, viruses and 
parasites, in inflammatory disorders, and possibly in cancer metastatis. In addition there 
are human disorders caused by disruptions in normal synthesis or catabolism of 
glycosylated molecules. 
Glycomics has trailed the explosive growth seen in genomics and proteomics. This is 
mostly because of the complex nature of carbohydrates and their unavailability.  The 
diversity of synthetic and naturally occurring carbohydrate structures means that their 
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automated chemical synthesis is not practical in the way it is for proteins and nucleic acids. 
Difficulties in chemical synthesis arise from the potential structural diversity of these 
compounds. Furthermore, difficulties spring because carbohydrates contain several 
hydroxyl groups of similar chemical reactivity: in chemically synthesizing a carbohydrate 
structure, each hydroxyl group must be distinguished from the rest in order to obtain the 
desired product with the correct stereochemistry and regiochemistry. Isolation of 
oligosaccharides from natural sources is difficult, time-consuming and expensive. 
Two major technological breakthroughs helped genomics and proteomics to blossom. The 
sequencing of oligonucleotides and proteins is automated and allows for the composition 
of an unknown sample to be determined quickly and reliably (Hunkapiller 1991), thereby 
providing a starting point for structure–function studies and the design of modifications. In 
addition, non-experts in an automated fashion can now achieve the synthesis of defined 
oligonucleotides (Caruthers 1985, 1991) and peptides (Atherton 1989). Modified 
oligonucleotides, peptides and proteins have found use as research tools and therapeutic 
agents.  
Access to pure carbohydrates for biological, biochemical and biophysical studies relies on 
chemical or enzymatic synthesis. Given the structural complexity of carbohydrates, regio- 
and stereoselectivity of glycosylation reactions is the key challenge for the assembly of 
oligosaccharides (ref). Synthetic chemists have developed increasingly powerful and 
versatile methods that have resulted in the assembly of ever more complex 
oligosaccharides and glycosaminoglycans. Still, the preparation of such structures is 
technically difficult, extremely time consuming and is carried out by a few highly 
specialized laboratories. Advances in enzymatic synthesis and in automated synthesis 
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planning have alleviated some of these challenges (ref), but still no automated synthesis 
method was available until recently to fuel the growing need for defined oligosaccharide 
structures as glycomics efforts gather steam. 
 
Iterative Solution Phase Synthesis by Danishefsky’s Glycal Method 
Danishefsky and coworkers has explored the use of glycals for the synthesis of 
oligosaccharides and glycoconjugates (Danishefsky 1996). Glycals may be converted into 
a number of glycosyl donors (Gordon 1990). For instance, epoxidation of glycals provides 
access to 1,2-anhydrosugars, which, in the presence of Lewis acid catalysts, proved to be 
excellent glycosyl donors in a range of glycosylation reactions (Scheme 1.1). The heart of 
this method involves the use of glycal-derived donors with suitably differentiated glycal 
acceptors, thereby providing the feature of smooth reiterability. Indeed, the adaptability of 
the logic of glycal assembly to solid phase synthesis has been demonstrated (Danishefsky 
1996).  
 The Lex-Ley nonasaccharide is not readily available from natural sources, but could be 
valuable for, e.g. developing anticancer vaccines. Remarkably, this oligosaccharide can 
ultimately be prepared from just three glycal precursors (Scheme 1.2). 
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Scheme 1.1 General Glycal Method. 
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Scheme 1.2 Solution phase synthesis of Lex-Ley nonasaccharide by glycal assembly 
method. 
The advantages of using glycal assembly method are as follows: 1) Syntheses of important 
and previously inaccessible oligosaccharides were achieved. 2) Reaction conditions used in 
this method are mild and general. The major drawback of using solution phase glycal 
assembly method was that the synthesis was laborious and time consuming. Since it is 
using solution phase chemistry, the isolation and purification of intermediates was difficult 
and time consuming. Also, overall yields were less than 1%. To circumvent this problem, 
Danishefsky and coworkers came up with the solid phase version of the glycal assembly 
method (Scheme 1.3). 
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Scheme 1.3 General strategy for the synthesis of oligosaccharides on a solid support using 
the glycal assembly method. 
In glycal assembly method the glycal terminus of compound 1.16 could be converted to a 
donor function as represented in a general way with compound 1.17. For example, 
compound 1.17 could be an isolable entity such as a 1,2-anhdyrosugar (Halcomb 1989), in 
which case E+ corresponds to an epoxidizing agent (Scheme 1.3). Moreover, through 
employment of a glycal as the solution based acceptor, the scheme benefits from relative 
simplicity in the identification of strategic hydroxyls for glycosylation.  
 
Wong’s OptiMer Method 
The Chi-Huey Wong’s research group at Scripps has prepared hundreds of mono- and 
disaccharides with different protecting group patterns to control glycosylation rate. This 
means that multiple components can be combined in the same reaction: the fastest 
component reacts first, then the next fastest, etc. A computer program (OptiMer) has been 
written that knows the relative reactivities of all the potential reactants. It can carry out 
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retrosynthetic analyses of complex carbohydrates and suggest a set of reactants that would 
allow synthesis of the oligosaccharide in one single reaction. In addition to condensing 
multiple reactions into one, this dramatically simplifies the laborious and inefficient 
processes of isolation and purification. 
Wong and coworkers synthesized Globo H, a carbohydrate that acts as antigen on breast 
cancer, using automated synthesis based on OptiMer technology (Sears 2001). The key to 
this approach is to have extensive quantitative data regarding the relative reactivities of 
different protected sugars. In Globo H, four monosaccharides are linked with one 
disaccharide to make Globo H hexasaccharide. This is then linked to a protein carrier to 
make a candidate breast cancer vaccine.  
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Scheme 1.4 Synthesis of the cancer antigen Globo H with OptiMer Technology. 
 
In the synthesis of Globo H, the sequence of Globo H is entered into the computer, which 
predicts the best building blocks to be used. These building blocks are then mixed in 
7
sequence, starting with the most reactive one, in the presence of activator. The product 
obtained is then purified and deprotected to give the target (Scheme 1.4). This technology 
for the one-pot synthesis of oligosaccharides is very efficient and predictable. It 
dramatically reduces labor associated with isolation and purification. The limitation of this 
method is that it requires access to a very large number of complex precursors. The 
synthetic method to make these complex precursors is still not available to non-chemists. 
 
Solid Phase Oligosaccharide Synthesis  
Solid phase synthesis has proven extremely efficient for the assembly of peptides and 
oligonucleotides as it does not require purification after each reaction step, utilizes excess 
reagent to drive reactions to completion and lends itself to automation (ref). A series of 
different approaches to solid phase oligosaccharide synthesis had been described and all 
critical aspects including the choice of synthetic strategy, differentially protected 
glycosylating agents, solid support materials, and linkers to attach the first monosaccharide 
to the support matrix were explored.  
Much progress concerning different aspects of solid phase oligosaccharide assembly had 
been made, but no generally applicable approach had evolved towards an automated solid 
phase oligosaccharide synthesizer. The salient features associated with the solid-phase 
synthesis that attracted researchers to explore oligosaccharide synthesis on solid support 
included ease of purification, higher yields by use of excess reagents, and synthesis speed. 
The importance of solid-phase synthesis was realized in the synthesis of peptides 
(Merrifield 1963, 1985), which had been automated by 1970 (Merrifield 1966). The impact 
of automated solid-phase synthesis of oligopeptide (Atherton 1989) and later 
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oligonucleotide (Caruthers 1985) on the development of biochemistry and biology of these 
molecules was enormous. Given the importance of oligosaccharides in biological systems, 
the motivation for developing similar methodology for the synthesis of oligosacchides is 
comprehensible.  
The problems associated with the synthesis of oligosaccharides on a polymer support are 
much greater than that of DNA and proteins. Unlike DNA and proteins that consist of 
linear chains, oligosaccharides have four potential positions for elongation. They are often 
branched, requiring flexible protecting group strategies for the effective differentiation of 
hydroxyl groups of similar chemical reactivity. The formation of a new stereogenic center 
in every coupling step further complicates oligosaccharide synthesis. Moreover, traditional 
acid-sensitive linker systems used in peptide synthesis are often incompatible with the 
Brönsted or Lewis acidic glycosylation conditions. Thus, the following problems need to 
be addressed in order to design a viable synthetic strategy: (1) methods of attachment of 
the carbohydrate to the polymeric support through the “reducing” or the “nonreducing” 
end, (2) choice of a polymer support, (3) selection of a linker that is stable to glycosylation 
and deprotection conditions, (4) a highly flexible protecting group strategy, (5) 
stereospecific and high-yielding coupling reactions, and (6) “on resin” methods to monitor 
coupling and deprotection reactions. 
The first solid-phase synthesis of oligosacchrides was reported in 1971 by Fréchet and 
Schuerch (Fréchet 1971).  Glucosyl donor 1.2 was attached to allyl alcohol functionalized 
Merrifield resin 1.1 by simple alcoholysis, preparing the first resin-bound monomer 1.3 
(Scheme 1.5). The yield was determined by weight gain of the resin and on the basis of 
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free hydroxyl groups of the latest attached sugar monomer. Cleavage from the resin was 
accomplished by ozonolysis followed by reduction of the ozonide with dimethyl sulfide. 
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Scheme 1.5 Early solid-phase approach to α-(1→6)-linked Mannose Trisaccharide 1.6.  
 
Zehavi and coworkers introduced the original concept of a photolabile linkage (Pillai 1980) 
of the first carbohydrate monomer to the polymeric phase (Zehavi 1973). They used 
essentially the same coupling conditions as Fréchet to synthesize disaccharide 1.8 in 
10
approximately 90% yield per coupling cycle (Scheme 1.6). Unfortunately, photolytic 
release of the disaccharide from the resin did not proceed as well on a preparative scale as 
in previous solution-phase model studies (Zehavi 1972), and debenzylated reducing 
isomaltose 1.9 was obtained in only 12.5% yield. 
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Scheme 1.6 Use of a new photocleavable linker for the solid-phase synthesis of 
Isomaltose. 
 
In addition to differently functionalized polystyrene (Merrifield’s resin), controlled-pore 
glass, as a nonswelling inorganic polymeric support was already evaluated for solid-phase 
oligosaccharide synthesis in its pioneering days. Schuerch reported the attempted 
glycosylation of a zirconia-coated glass surface carrying unsaturated alcohol acceptor sites, 
but only poor glycosylation yields could be achieved (Eby 1975). 
The pioneering work in solid-phase oligosaccharide synthesis provided the foundation for 
the rapid progress that several research groups have made in the area. These early 
approaches explored some of the important fundamental issues, including different 
synthetic strategies (donor- vs. acceptor-bound synthesis), various solid supports (soluble 
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and insoluble), and linker systems. Unfortunately, at that time this approach was not 
competitive with the more classical solution chemistry methods, due mainly to the lack of 
suitable glycosidation reactions (Fréchet 1980), that would meet the demands and 
conditions of solid-phase synthesis. The considerable loss of sugar donors during each 
coupling steps also compromised the advantages of solid-phase paradigm, since it was less 
effective and more expensive than synthesis in solution-phase. Major advances in solution-
phase oligosaccharide synthesis with regard to donor reactivity, glycosylation selectivity, 
protecting group diversity, and analytical techniques were necessary before solid-phase 
oligosaccharide synthesis set the stage for the developments. 
PEG and other soluble polymers have a clear advantage over resin-based solid supports in 
several respects (Gravert 1997). Firstly, most of the synthetic steps can be performed under 
homogeneous conditions, thereby avoiding the pseudo high dilution problem of solid-
phase reactions. Secondly, the loading density of the monosaccharide primer, as well as the 
quality of the product, can easily be estimated after each step in a straightforward manner 
by means of conventional lH-NMR spectroscopy. PEG bound oligosaccharides can be 
easily recovered by precipitation from ethereal or alcoholic solvents. Synthesis on soluble 
polymers seems to have advantages associated with both solution-phase and solid-phase 
chemistry. This aspect was clearly demonstrated by Krepinsky and co-workers (Douglas 
1995) and van Boom and co-workers (verduyn 1993) in their highly efficient synthesis of 
oligomannoside and the phytoalexine elicitor, respectively. Soluble support is likely to 
have less potential compared with solid support for utility in library synthesis using the 
split-mix method, a popular technique in combinatorial chemistry that is a powerful tool 
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for making libraries comprising large numbers of compounds, as well as in the future 
automation of oligosaccharide synthesis. 
Two possible approaches immediately present themselves for the synthesis of 
oligosaccharides on solid support. These involve the decision as to the mode of attachment 
of the first carbohydrate to the matrix. 
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Scheme 1.7 Acceptor-bound and donor-bound glycosylation strategies for the synthesis of 
oligosaccharides. 
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In method 1, the first carbohydrate is anchored via its “reducing” end (Scheme 1.7). Here, 
the support-bound carbohydrate will function as acceptor in the coupling step to a solution-
based donor. As the next cycle is contemplated, the temporary protecting group P must be 
removed in the now elongated, resin-bound carbohydrate construct. 
Connection of the glycosyl acceptor to the solid-support allows for the use of excess donor, 
a feature that can be used to drive reactions to completion. Nevertheless, this strategy 
requires a capping step to prevent the formation of deletion sequences, which would 
complicate final purification. Moreover, and perhaps most importantly for the broader 
context of glycoconjugate synthesis, the completed oligosaccharide construct would likely 
require retrieval from the solid matrix before conjugation to the peptide or lipid, unless this 
portion were already present as part of the linker to the solid support. 
In method 2 (Scheme 1.7), the oligomer undergoing elongation is mounted to the solid 
support somewhere in the nonreducing region. In this case the reducing end (i.e., glycosyl 
donor portion) of the molecule is available for coupling to a solution-based acceptor. The 
main drawback of donor-bound strategy has to be considered. Most side reactions during 
glycosylations involve the glycosyl donor and thus result in termination of chain 
elongation. A reduction of the overall yield in the donor-bound strategy is the 
consequence. These inherent challenges not withstanding, an impressive array of complex 
oligosaccharide structures have been synthesized by Danishefsky and co-workers using the 
glycal assembly method under the donor-bound paradigm (Seeberger 1998). 
Synthetic chemistry has finally advanced to the point that solid phase oligosaccharide 
synthesis is also feasible, and can now be automated. Seeberger and coworkers in 42% 
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yield in 9 h achieved automated synthesis of protected Leishmania antigen successfully 
(Scheme 1.8). 
Automated solid phase synthesis is remarkably efficient and is often 10 times faster and 
higher yielding than corresponding solution phase syntheses. Automation makes synthetic 
methodology accessible to non-chemists. Even with automation, a bewildering number of 
specialized reactants are still required. This problem must be solved if automated 
synthesizers are to become commercially available. 
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Scheme 1.8 Automated synthesis of Leishmania tetrasaccharide. 
 
Hydrophobically Assisted Switching Phase Synthesis 
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Hydrophobically assisted switching phase (HASP) synthesis is a concept that allows the 
choice between the advantages of solid-supported chemistry and those of solution-phase 
synthesis. In this method, sugar is attached to a sufficiently long hydrophobic anchor that 
can be adsorbed and desorbed quantitatively. The retention of single hydrocarbon chains 
(C8-C20) hydrocarbon chain depended strongly on the polarity and charge of the head 
group, rendering these molecules unsuitable as high-yielding and reversible tags. On the 
contrary, a sufficiently long, hydrophobic double chain anchor (C18) was both adsorbed 
and desorbed quantitatively.  
OO
O
O
O
O
O
Ph
CCl3
NH
MeO
MeO
OHO
HO OH
OHO
HO
O
O
OHO
HO
O
OHO
HO
O
OHO
HO
R
HO
OO
O
MeO
MeO
O
O
POAc n
OO
O
MeO
MeO
O
O
H n
TMSOTf, DCM
NaOMe, MeOH
TFA, H2O
1.36
1.37
1.38
1.39
1.40
n = 1-5  
Scheme 1.9 Hydrophobically assisted switching phase synthesis of a library of 
rhamnolipids. 
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The doublechain HASP anchor 1.37 was glycosylated with rhamnosyl donor 1.38. RP-18 
silica was added, the reaction concentrated and all unlabeled material was easily removed 
by washing with 80% MeOH/water. Deprotection of phenoxy acetate was performed while 
attached to the solid phase. MgSO4 was added to the solid support, and the clean products 
were released with DCM. 
 
Fluorous Oligosaccharide Synthesis 
Based on the difference in solubility of fluorous-tagged compounds from the non-fluorous 
compounds, a novel acyl fluorous protecting group (Bfp) was developed by Inazu and 
coworkers (Miura 2001). A natural synthetic oligosaccharide was synthesized using this 
method with minimal chromatography purification. After each step the reaction mixture 
was partitioned between the organic phase and the fluorous phase. Sugars containing 
fluorous protecting group were extracted in the fluorous phase and everything else in 
organic phase. 
 
Chemoenzymatic Synthesis of Oligosaccharides 
As an alternative to chemical synthesis, many biochemists and bioorganic chemists have 
explored the use of glycosidases and glycosyltransferases in the synthesis of 
oligosaccharides and glycoconjugates. The appeal of this approach is obvious: Nature has 
already figured out how to make all of the naturally occurring oligosaccharides, and if we 
could borrow from her toolbox we’d save a lot of time and effort. The use of 
glycosyltransferases and glycosidases has strengths and weaknesses that are in many ways 
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complementary to those of chemical synthesis. The main advantage of this method is that 
enzyme-catalyzed reactions are very stereo- and regio- selective and do not require 
protected donors for coupling reactions. The major drawback is that most requisite 
enzymes are not readily available, and those that are available are very expensive. 
 
Carbohydrate Microarrays 
While the importance of carbohydrates in biological systems is well documented, 
screening techniques to further elucidate their function are still needed. These arrays will 
facilitate screening of complex carbohydrate libraries to identify ligands and define 
specificity of carbohydrate-protein interactions. A better understanding of protein-
carbohydrate interactions would greatly aid in the elucidation of intercellular signaling 
pathways, possibly leading to improved diagnostic and therapeutic tools. 
Wang and coworkers described microarrays of polysaccharides and glycoproteins on 
nitrocellulose-coated glass slides (Wang 2002). They used a high-precision robotic arrayer 
that was developed for cDNA and the spots were generated without derivatization (Scheme 
1.10). These were air dried to allow adsorption (noncovalent immobilization) onto the 
hydrophobic surface. All were immobilized, although the efficiency of immobilization was 
dependent on molecular mass; the larger molecules were better retained than the smaller 
molecules. To overcome this limitation, Feizi and colleagues have established a microarray 
system in which the oligosaccharides are linked to lipid (Fukui 2002). The 
oligosaccharides, containing two to twenty monosaccharide residues, were linked by 
reductive amination to the amino phospholipid 1,2-dihexadecyl-sn-glycero-3-
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phosphoethanolamine or its anthracene-containing fluorescent analogue (Scheme 1.11). 
These neoglycolipids were attached to the nitrocellulose membrane containing glass slide. 
It was shown that they could be robustly attached by noncovalent absorption. 
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Scheme 1.10 Noncovalent immobilization of polysaccharides on slides for microarray 
formation. 
 
Willats and coworkers used relatively hydrophobic black polystyrene produced with a 
physical surface modification that increased the surface area available for noncovalent 
adsorption (Scheme 1.10, Willats 2002). 
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Scheme 1.11 Noncovalent immoblization of lipid modified oligosaccharides onto 
nitrocellulose membrane coated glass slide. 
 
Several methods were used to covalently attach oligosaccharides onto the glass slide. 
Mrksich and colleagues using Diels-Alder reaction achieved covalent attachment of 
oligosaccharides onto the glass slide (Houseman 2002, Scheme 1.12). Shin’s group has 
reported another approach another approach to carbohydrate microarray fabrication (Park 
2002, 2004). They used hetero-Michael addition reaction to covalently attach maleimide-
modified carbohydrates to thiol coated glass slide (Scheme 1.13). 
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Scheme 1.12 Covalent attachment on a gold surface by Diels-Alder reaction. 
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Scheme 1.13 Covalent Immobilization on a thiol-coated glass slide by hetero-Michael 
addition reaction.  
 
The field of carbohydrate microarrays is in its infancy and further developments are 
expected, such as new fabrication strategies, new array surfaces, and printing methods. The 
results of the several ‘proof of concept’ experiments reported thus far have been very 
promising, and it is envisaged that microarrays of oligosaccharides and also 
glycoconjugates will revolutionize surveys of proteins for carbohydrate-binding activities. 
Various groups have used this technology to create microarrays of complex carbohydrates. 
Seeberger and coworkers used microarrays to study interactions of heparin-like 
glycosaminoglycans with fibroblast growth factors (FGF-1 and FGF-2), two important 
heparin-binding proteins (de Paz 2006). Recently Hseih-Wilson’s group reported the first 
example of synthetic chondroitin sulfate (CS) microarrays and used these microarrays to 
identify a previously unknown interaction between chondroitin sulfate-E (CS-E) and tumor 
necrosis factor-α (TNF- α) (Tully 2006).  
In summary complex oligosaccharides have been synthesized successfully using solid-
phase synthesis and other methods. To study protein-carbohydrate interactions using 
microarray methods available, the oligosaccharides after cleavage from the solid support 
needs further modification. An easy approach would be to use a linker that would facilitate 
the synthesis of oligosaccharide and also could be used directly for microarrays without 
further modification.  
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CHAPTER 2:  FLUOROUS-BASED CARBOHYDRATE 
MICROARRAYS 
 
A paper published in the Journal of the American Chemical Society1 
Kwang-Seuk Ko,2,3 Firoz A. Jaipuri,2 and Nicola L. Pohl2,4 
 
A paper published in the Journal of Fluorine Chemistry1 
Sreeman Mamidyala,3 Kwang-Seuk Ko,2 Firoz A. Jaipuri,2 Gisun Park,2 and Nicola L. 
Pohl2,5 
 
Introduction 
The success of microarrays, such as DNA chips, for biosample screening with minimal 
sample usage has led to a variety of technologies for assays on glass slides (Tomizaki 
2005, Niemeyer 1999, Schena 1996). Unfortunately, for small molecules, such as sugars, 
these methods usually rely on covalent bond formation, which requires unique functional 
handles and multiple chemical steps (Shin 2005, Biskup 2005). Herein, we present a new 
simpler concept in microarray formation that is based on noncovalent fluorous-based 
                                                 
1 Reproduced with permission of J. Am. Chem. Soc. (2005), 127, 13162-13163. Copyright 
2005 American Chemical Society and J. Fluor. Chem. (2006), 127, 571-579. 
2 Graduate student, undergraduate student, and Assistant Professor, respectively, 
Department of Chemistry and the Plant Sciences Institute, Iowa State University 
3 Primary researcher and an author 
4 Author for correspondence 
5 Author for correspondence 
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interactions and demonstrate the strength of these interactions in the direct formation of 
carbohydrate microarrays for biological screening.  
Unlike comparable lipid tails interacting with hydrophobic solid phases (Bauer 2005, Fang 
2003, Fazio 2002), a single C8F17 tail is sufficient to bind biomolecules, such as peptides, 
to fluorinated solid supports (Brittain 2005, Zhang 2004, Filippov 2002). The use of such 
fluorinated solid supports for affinity chromatography can substantially simplify the 
purification of synthetic carbohydrate intermediates in a process amenable to automation 
(Figure 2.1) (Manzoni 2004, Jing 2004, Curran 2001). An additional potential advantage of 
a fluorous-based approach is the direct formation of microarrays; the production of 
carbohydrate microarrays from compounds made on solid-phase still requires multiple 
solution-phase deprotection and derivatization steps (Adams 2004). 
                         
Figure 2.1 Strategy for the synthesis of carbohydrates and direct formation of fluorous-
based carbohydrate microarrays (Taken with permission by The American Chemical 
Society from Ko 2005). 
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We began our studies with the design of a suitable fluorous tag for carbohydrate synthesis 
that could survive the necessary sequential reaction conditions and also be removed if 
desired. An allyl group would be orthogonal to the trichloroacetimidate coupling 
conditions and other deprotection conditions. Therefore, to create a fluorous allyl 
protecting group as well as potential anchor for microarray formation, a fluorous tail was 
synthesized in one step by reaction of cis-1,4-butenediol with substoichiometric amounts 
of 1H,1H,2H,2H-perfluorodecyl iodide to produce an alcohol for use in glycosylations (By 
Kwang).  
Sugars commonly found in plants were chosen as initial targets to test the feasibility of a 
noncovalent fluorous-based array for protein-binding studies (Scheme 2.1). Genome 
sequencing projects have revealed that the number of genes related to carbohydrate 
metabolism is far greater in plants, such as Arabidopsis thaliana, than in animals or fungi 
(Henrissat 2001). In addition to providing an understanding of plant biology, the study of 
carbohydrate-protein interactions in plants could lead to the discovery of new sugar-
binding lectins for use as glycobiology tools (Lis 1998). The known trichloroacetimidates 
of peracylated mannose (By Kwang) (Schmidt 1980), galactose (Schmidt 1991), and N-
acetylglucosamine (By Kwang) (Schmidt 1994) were reacted with the fluorous-tagged allyl 
alcohol, and subsequent deacylation and hydrogenation of the double bond yielded the 
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initial array components 3.1-3.3.            
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Scheme 2.1. Fluorous-tagged sugars (3.1-3.4) included in a microarray for screening with 
carbohydrate-binding proteins (Taken with permission by The American Chemical Society 
from Ko 2005). 
 
Synthesis of Fucose Donor 
Although neighboring-group participation could be used to control the stereochemistry of 
glycosylation for mannose, galactose, and N-acetylglucosamine, the synthesis of -linked 
fucose required a different approach. Fucose glycosyl donors are usually built with 
nonparticipating benzyl protecting groups to provide predominantly the -configured 
glycosylation products. Unfortunately, such electron-donating groups on a 6-deoxysugar 
also serve to make the resulting glycosidic linkage more acid sensitive. Several strategies 
alleviate this problem, for example, the use of more electron-withdrawing halobenzyl 
groups (Pohl 1997) or replacing the 3- and 4-OH protecting groups with an ester (Plante 
2001, Amer 2003) that can potentially serve as a distant participating group. The latter 
approach is appealing, but requires an additional basic deprotection step. To avoid this 
extra step, we decided to test if a benzyl carbonate protecting group could serve the same 
purpose with the advantage of removal during the hydrogenation step. The requisite 
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glycosyl donor was synthesized from the known allylated compound (Khattuntseva 2000) 
3.5 in three steps to provide the desired trichloroacetimidate 3.6 (Scheme 2.2). This donor 
was glycosylated with the fluorous-tagged alcohol using trimethylsilyl triflate to yield only 
the axially linked product in 90% yield. Indeed, the benzyl carbonate could serve to direct 
formation of the -anomer and be removed by hydrogenation.  
         
3.4
O
OCBz
OCBz
OBn
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3) Cl3CCN, Cs2CO3, 
CH2Cl2, 4 Å M.S., 92%
3.5  
Scheme 2.2. Synthesis of Fucose Donor (Taken with permission by The American 
Chemical Society from Ko 2005). 
 
Carbohydrate Microarrays 
After synthesis of the requisite fluorous-tagged sugars, the next challenge was to find a 
suitable fluorinated surface. Solutions of each sugar were spotted onto a commercially 
available glass microscope slide coated with a Teflon/epoxy mixture employing a standard 
robot used for DNA arraying. The spots were dried, incubated with a solution of the 
fluorescein isothiocyanate-labeled jack bean lectin concanavalin A (FITC-ConA) for 20 
min, rinsed repeatedly with assay buffer and distilled water, and then scanned with a 
standard fluorescent slide scanner. The scan clearly showed binding of FITC-ConA only to 
the mannose-containing spots (By Kwang). The anomeric position could be distinguished 
as the β-linked GlcNAc 3.2 was not recognized.  
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This lectin experiment demonstrated the ability of the C8F17 tail to anchor the 
carbohydrates to the slide surface even after repeated washes. However, the slide was also 
intrinsically and unevenly fluorescent at 488 nM, a wavelength that is commonly used to 
detect labeled analytes. Clearly, a new approach was necessary to obtain an optically and 
fluorescently clear surface for the formation of compound microarrays. To this end, a glass 
microscope slide was reacted (Maoz 1984) with a fluoroalkylsilane to provide a clear 
coating on which water forms beads.  
With the new microarray substrate in hand, we next probed the scope of a fluorous-based 
microarray approach for compound screening. Fluorous-tagged sugars were spotted on the 
coated slide using an arraying robot, and then the slides were incubated with FITC-labeled 
lectins (Figure 2.2). To test the reproducibility of the process, the same concentration of 
sugar was spotted repeatedly. In addition, several different concentrations of sugars were 
spotted. To test the ability of the array to withstand detergents often included in biological 
screens, the labeled plant lectin from the bush Erythrina crystagalli (FITC-ECA) was used 
to probe the microarrays with Tween-20. The array withstood the 20 min incubation time 
and repeated rinsing with this detergent-containing buffer.  
             
Figure 2.2. Fluorescence images of arrayed carbohydrates probed with FITC-labeled 
lectins. Columns of 4 spots each of 2, 1, 0.5, and 0.1 mM carbohydrates were incubated for 
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20 min with FITC-ConA (top) or FITC-ECA with 1%(Taken with permission by The 
American Chemical Society from Ko 2005). 
 
A fluorous-based microarray method allows the facile formation of a range of carbohydrate 
chips for the plant and other sciences using synthetic sugars produced with the aid of 
fluorous-tagged synthesis. Efforts are underway to automate portions of the solution-phase 
fluorous-based synthetic process and to incorporate enzymatic steps to expand the scope of 
carbohydrates that can be easily arrayed for biological screening. Although not limited to 
carbohydrates, the approach should be especially valuable for the production of arrays 
containing compounds, such as glycosaminoglycan fragments, that contain nucleophiles 
that complicate current defined covalent attachment strategies.  
These initial experiments, however, used only simple monosaccharides. Ideally, the 
method would be applicable to a range of synthetic carbohydrates. To expand the scope of 
these arrays, we report below the first syntheses of arabinose (synthesized by Gisun), 
rhamnose (synthesized by Gisun), lactose (synthesized by Kwang), maltose (synthesized 
by Kwang), and glucosamine tagged with a single C8F17-tail (synthesized by Sreeman); 
their incorporation into expanded carbohydrate microarrays; and screening of this 
microarray against two lectins to test the scope of a fluorous-based microarray method. 
In order to anchor carbohydrates onto an array surface, a suitable fluorous tag is needed. 
This tag needs to survive the necessary sequential reaction conditions and also be removed 
if desired. Our previous work demonstrated that an allyl group works well with standard 
tricholoroacetimidate coupling conditions and other deprotection conditions. Reaction of 
cis-1,4-butenediol with 1H,1H,2H,2H-perfluorodecyl iodide produces an alcohol with the 
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requisite alkene spacer for use in glycosylations. The reliable synthesis of this tag on a 
larger scale proved difficult, however, as iodide elimination can compete with nucleophilic 
substitution. Therefore, a slightly modified tag was developed. An additional methylene 
spacer between the leaving group and the electron-withdrawing fluoroalkane was added to 
reduce the acidity of the hydrogen beta to the leaving group. To this end, commercially 
available 3-(perfluorooctyl)propanol 3.7 was mixed with methanesulfonyl chloride to 
provide mesylate derivative 3.8 quantitatively. This electrophile was then reacted with cis-
1,4-butenediol to produce fluorous-tagged alcohol 3.9 in 70% yield for use in subsequent 
glycosylation reactions (Scheme 2.3). 
 
RO C8F17
OHHO
3.7; R = H
3.8; R = Ms
3.9
OHO C8F17
 
Scheme 2.3. Synthesis of a new fluorous linker (Taken with permission by Journal of 
Fluorine Chemistry from Mamidyala 2006). 
 
Sugars 3.10-3.17 were chosen as targets for glycosylation reactions with alcohol 3.9 
(Figure 2.3). Screening of microarrays containing these sugars could lead to the discovery 
of new carbohydrate-binding specificity profiles by lectins for use as glycobiology tools 
(Lis 1998). Of particular interest are the two disaccharides (3.16, 3.17) and the charged 
amino-sugar (3.10) to test if such compounds are viable for inclusion in microarrays based 
on noncovalent fluorous–fluorous interactions. 
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Figure 2.3. Fluorous-tagged sugars (3.10-3.17) included in a microarray for screening with 
carbohydrate-binding proteins (Taken with permission by Journal of Fluorine Chemistry 
from Mamidyala 2006). 
 
With the fluorous-tagged carbohydrates in hand, we next probed the ability of the single 
C8F17-tail to anchor these mono- and disaccharides to a glass slide surface even after 
repeated washes. The fluorous-tagged carbohydrates 3.10-3.17 were dissolved in 80% 
methanol/water and were spotted onto fluoroalkylsilane-derivatized glass slides employing 
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a standard robot used for DNA arraying. The slides then were incubated for 30 min with 
the commercially available FITC (fluorescein isothiocyanate)-labeled lectins from Triticum 
vulgaris (wheat germ, FITC-WGA) (Szentkuti 1998) in phosphate buffered saline (PBS 
buffer) (0.25 M) and Arachis hypogaea (peanut, FITC-PNA) in PBS buffer (0.5 M) and 
rinsed repeatedly with the assay buffer followed by distilled water. After drying, the slide 
was scanned with a standard fluorescent slide scanner at 488 nm to reveal the 
carbohydrate-binding specificities of these two lectins. As expected (Szentkuti 1998) the 
wheat germ lectin WGA bound only to the fluorous-tagged N-acetylglucosamine (3.11) 
(Figure 2.4).  
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Figure 2.4. A scan at 488 nm of glass slides arrayed with fluorous-tagged carbohydrates 
after incubation with fluorescently-labeled lectins (Taken with permission by Journal of 
Fluorine Chemistry from Mamidyala 2006). 
 
In contrast, the peanut lectin PNA bound to both galactose (3.13) and lactose (3.16) in the 
array experiment. This lectin is known to bind to galactose both alone and in the context of 
the lactose disaccharide (Szentkuti 1998) and (Caffarena 2002). This experiment vividly 
demonstrates that the disaccharide is retained on the fluorous-derivatized glass slides under 
the conditions required for screening of proteins for their carbohydrate-binding 
specificities. 
 
Conclusions 
In conclusion, our new method for the facile fabrication of carbohydrate microarrays by 
using the noncovalent immobilization of carbohydrates on fluorous derivatized glass slides 
clearly can be extended beyond monosaccharides. Screening of these carbohydrate 
microarrays against two lectins demonstrates that the noncovalent fluorous–fluorous 
interaction is sufficient to retain not only mono- but also disaccharides under biological 
assay conditions. As the fluorous tag also facilitates purification during synthesis, this 
microarray approach should be particularly valuable for screening of synthetic 
carbohydrate libraries. Future work will test the scope of using noncovalent fluorous 
interactions for the production of microarrays that contain additional charged compounds 
such as glycosaminoglycan fragments (Kovensky 1999) and (Rele 2004) and larger 
saccharides as well as other classes of biomolecules such as peptides and nucleic acids. 
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Experimental 
All reagents were purchased from Aldrich. Dichloromethane was distilled over calcium 
hydride THF and toluene was used from solvent purification towers. Amberlyst 15 ion-
exchange resin was washed repeatedly with methanol before use. All other commercial 
reagents and solvents were used as received without further purification. The reactions 
were monitored and the Rf values determined using analytical thin layer chromatography 
(tlc) with 0.25 mm EM Science silica gel plates (60F-254). The developed TLC plates 
were visualized by immersion in p-anisaldehyde solution followed by heating on a hot 
plate. Flash chromatography was performed with Selecto Scientific silica gel, 32-63 µm 
particle sizes. Fluorous phase chromatography was performed using fluorous solid-phase 
extraction cartridges containing silica gel bonded with perfluorooctylethylsilyl chains 
(Fluorous Technologies Inc.; Pittsburgh, PA). All other Fluorous reagents were also 
obtained from Fluorous Technologies, Inc. All moisture-sensitive reactions were 
performed in flame- or oven-dried glassware under a nitrogen atmosphere. Bath 
temperatures were used to record the reaction temperature in all cases run without 
microwave irradiation. All reactions were stirred magnetically at ambient temperature 
unless otherwise indicated.  
1H NMR and 13C NMR spectra were obtained with a Bruker DRX400 and Varian 
VXR300. 1H NMR spectra were reported in parts per million (δ) relative to CDCl3 (7.27 
ppm) or CD3OD (4.80) as an internal reference. 13C NMR spectra were reported in parts 
per million (δ) relative to CDCl3 (77.23 ppm) or CD3OD (49.15 ppm). A Shimadzu LCMS 
2010 quadrupole mass spectrometer (Shimadzu Scientific Instruments, Columbia, MD) 
equipped with and electronspray ionization (ESI) source was used in positive ion mode. 
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Synthesis of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-D-
galactopyranoside.  
2,3,4,6-tetra-O-acetyl-α/β-D-galactopyranoside trichloroacetimidate8 (77.0 mg, 0.16 
mmol) and 1H,1H,2H,2H-perfluorodecyloxybutenyl alcohol (69.0 mg, 0.13 mmol) were 
dissolved in dichloromethane (2 mL) and the mixture was cooled down to –15 °C. 
TMSOTf  (12 µL, 0.065 mmol) was added and the reaction mixture was stirred at –15 °C 
for 30 min. The reaction was quenched with triethylamine (0.1 mL) and concentrated. The 
crude product was purified by solid-phase extraction using fluoro flash column. Non-
fluorous compounds were eluted with 80% MeOH/water and the desired product was 
eluted by 100% MeOH. (1H,1H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-
β-D-galactopyranoside as a colorless oil, 98.8 mg, 0.11 mmol, 90%). 
Rf: 0.52 (1:1 EtOAc/hexane) 
1H NMR (CDCl3, 400 MHz): δ (ppm) 5.69 – 5.74 (m, 2H), 5.38 (d, 1H, J = 3.3 Hz, H-1), 
5.21 (dd, 1H, J = 10.5, 2.7 Hz), 5.01 (dd, 1H, J = 10.5, 3.3 Hz), 4.48 (d, 1H, J = 7.8 Hz), 
4.36 – 4.41 (m, 1H), 4.04 – 4.26 (m, 6H), 3.86 – 3.91 (m, 1H), 2.14 (s, 3H), 2.04 (s, 3H), 
2.05 (s, 3H), 1.97 (s, 3H).   
13C NMR (CDCl3, 100 MHz): δ (ppm) 170.5, 170.4, 170.3, 169.6, 129.4, 128.9, 100.3, 
71.1, 70.9, 68.9, 67.2, 66.5, 64.9, 62.1, 62.1, 61.4, 20.9, 20.8(2), 20.7. 
MS (ESI) m/z = 887 [M + Na]+ 
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Synthesis of 1H,1H,2H,2H-perfluorodecyloxybutanyl-β-D-galactopyranoside.  
1H,1H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (50 
mg, 0.058 mmol) was dissolved in ethanol (3 mL) and 5% Pd/C (10 mg) was added. The 
reaction mixture was put under hydrogen atmosphere and stirred for 1 h. It was then 
filtered over Celite and ethanol was removed under reduced pressure to give the 
hydrogenated product in quantitative yield. To a solution of the resulting compound (45 
mg, 0.052 mmol) in methanol (3 mL) was added K2CO3 (4 mg, 0.026 mmol) and the 
reaction mixture was stirred for 2 h. The mixture was then neutralized using Amberlyst-15 
ion-exchange resin and filtered. The solvent was removed under reduced pressure and 
1H,1H,2H,2H-perfluorodecyloxybutanyl-β-D-galactopyranoside was obtained as white 
solid (0.058 mol, 40 mg, 100%). 
Rf: 0.23 (methanol/ethyl acetate/hexane/2/2/3). 
1H NMR (CD3OD, 400 MHz): δ (ppm) 4.17 (d, 1H, J = 5.4 Hz), 3.44 – 3.91 (m, 12H), 
2.01 (m, 2H), 1.60 – 1.70 (m, 4H).  
13C NMR (CD3OD, 100 MHz): δ (ppm) 103.6, 75.2, 73.7, 71.2, 69.2, 69.1, 68.9, 61.4, 
61.3, 28.8 (2), 25.9(2).  
MS (ESI) m/z = 721 [M + H]+ 
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Synthesis of Allyl-2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranoside.  
Allyl-2-O-benzyl-α-D-fucopyranoside (917 mg, 3.12 mmol) was dissolved in methylene 
chloride (15 mL) and cooled to 0 °C. TMEDA (434 mg, 3.74 mmol) and 
benzylchloroformate (1.20 g, 6.86 mmol) were added. The reaction mixture was stirred at 
0 °C for 45 min and quenched with water (10 mL). The organic layer separated and the 
aqueous layer was extracted with methylene chloride (2 x 40 mL), washed with HCl (2N, 
20 mL), brine (20 mL), and dried over MgSO4. After removal of the solvent under reduced 
pressure, the crude product was purified by flash column chromatography on silica gel 
using 25% EtOAc/hexane as eluent. The product was obtained as clear gel (1.7 g, 3.02 
mmol, 92%). 
Rf: 0.48 (1:1 EtOAc/hexane) 
1H NMR (CDCl3, 400 MHz): δ (ppm) 7.25 – 7.40 (m, 15 H), 5.88 – 5.94 (m, 1 H), 5.15 – 
5.36 (m, 8H), 4.82 (d, 1H, J = 4 Hz, H-1), 4.70 (d, 1H, J = 12 Hz), 4.53 (d, 1 H, J = 12 
Hz), 4.13 – 4.17 (m, 2H), 3.98 (dd, 1H, J = 12.8, 6.4 Hz), 3.90 (dd, 1H, J = 9.6, 3.6 Hz), 
1.17 (d, 3H, J = 6.8 Hz).  
13C NMR (CDCl3, 100 MHz): δ (ppm) 155.3, 154.4, 138.2, 135.3, 135.1, 133.7, 128.6, 
128.6, 128.5, 128.5, 128.4, 128.1, 127.9, 127.8, 117.9, 96.3, 75.6, 74.3, 73.7, 73.4, 69.9, 
69.9, 68.6, 64.3, 15.8. 
MS (ESI) m/z = 585[M + Na]+ 
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Synthesis of 2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranose.  
Palladium chloride (685 mg, 3.87 mmol) and sodium acetate (635 mg, 7.74 mmol) were 
dissolved in AcOH/water mixture (5:1, 36 mL). The mixture was heated in commercial 
microwave oven at 80 °C for 5 min. The reaction was then put on an 80 °C oil bath and 
compound 2 (1.45 g, 2.58 mmol) in AcOH was added dropwise. The reaction mixture was 
heated for 5 min and allowed to cool down to rt. It was poured into water and extracted 
with ether (2 x 60 mL). The combined organic layer was washed with NaHCO3 (2 x 40 
mL), water (40 mL), and brine (20 mL) and dried over MgSO4.The solvent was removed 
under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel using 32% EtOAc/hexane as eluent. The product of 2-O-
benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranose was obtained as mixture of anomers. 
Yield = 88% 
Rf: 0.44 (1:1 EtOAc/hexane) 
1H NMR (CDCl3, 400 MHz): δ (ppm) 7.15 – 7.36 (m, 19H), 5.12 – 5.22 (m, 8H), 4.81 – 
4.90 (m, 1H), 4.50 – 4.74 (m, 3H), 4.31 – 4.49 (m, 1H), 3.82 – 4.24 (m, 3H), 1.21 (d, 1H, J 
= 6.4 Hz), 1.15 (t, 3H, J = 6.4 Hz). 
13C NMR (CDCl3, 100 MHz): δ (ppm) 137.7, 135.2, 129.2, 129.2, 128.7, 128.7, 128.7, 
128.7, 128.7, 128.7, 128.6, 128.6, 128.5, 128.5, 128.5, 128.5, 128.4, 128.4, 128.3, 128.3, 
128.3, 128.3, 128.2, 128.1, 128.0, 128.0, 128.0, 97.8, 91.8, 75.6, 75.5, 75.5, 75.2, 74.7, 
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74.5, 74.3, 74.2, 74.1, 73.9, 73.6, 73.6, 72.7, 70.2, 70.2, 70.2, 70.1, 69.1, 65.0, 64.7, 64.6, 
62.6, 43.4, 26.8, 21.9, 16.1, 16.0.   
MS (ESI) m/z = 523 [M + H]+ 
O
OCbz
OCbz
OBn
OH
O
OCBz
OCBz
OBn
O CCl3
NH
 
 
Synthesis of 2-O-benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranoside 
trichloroacetimidate. 
 To a solution of 2-O-benzyl-3,4-di-O-carbobenzyl-α-D-fucopyranose (1.17 g, 2.24 mmol) 
in dichloromethane (10 mL) were added powdered 4Å molecular sieves (100 mg) and 
trichloroacetonitrile (2.2 mL, 22.4 mmol). The reaction was stirred for 30 min and Cs2CO3 
(802 mg, 2.46 mmol) was added. The reaction mixture was further stirred for 45 min and 
filtered over Celite. The eluent was concentrated and the crude product was purified by 
flash column chromatography on silica gel using 28% EtOAc/hexane as eluent to provide 
2-O-benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranoside trichloroacetimidate as a white 
solid (1.43 g, 2.1 mmol, 92%). 
Rf: 0.46 (1:1 EtOAc/hexane) 
1H NMR (CDCl3, 400 MHz): δ (ppm) 8.68 (s, 1H), 7.19 – 7.39 (m, 15H), 5.78 (d, 1H, J = 
8.1 Hz), 5.15 – 5.29 (m, 6H), 4.96 (dd, 1H, J = 9.9, 3.3 Hz), 4.83 (d, 1H, J = 11.0 Hz), 4.67 
(d, 1H, J = 11.0 Hz), 3.94 – 4.00 (m, 1H), 1.27 (d, 3H, J = 6.3 Hz). 
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13C NMR (CDCl3, 100 MHz): δ (ppm) 161.3, 155.4, 154.5, 137.9, 135.2, 135.1, 128.8, 
128.8, 128.8, 128.81, 128.8, 128.5, 128.5, 128.4, 127.9, 127.9, 98.1, 77.1, 75.6, 75.4, 74.5, 
70.4, 70.3. 69.9,16.2. 
MS (ESI) m/z = 667 [M + H]+ 
 
OC8F17 O
HO
O
OCBz
OCBz
OBn
O CCl3
NH
O
OCBz
OCBz
OBn
O
C8F17
 
 
Synthesis of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2-O-benzyl-3,4-di-O-
carbobenzyl-α-D-fucopyranoside.  
To a solution of 2-O-benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranoside 
trichloroacetimidate (185.0 mg, 0.28 mmol) and 1H,1H,2H,2H-perfluorodecyloxybutenyl 
alcohol (123.0 mg, 0.23 mmol) in dichloromethane (5 mL) were added powdered 4Å 
molecular sieves (10 mg) and the mixture was cooled down to -15 oC. TMSOTf (42 µL, 
0.23 mmol) was added and the reaction mixture was stirred at –15 °C for 30 min. The 
reaction was quenched with triethylamine (0.1 mL) and concentrated. The crude product 
was purified by solid-phase extraction using fluoro flash column. Non-fluorous compounds 
were eluted with 80% MeOH/water and the desired product was eluted by 100% MeOH 
(1H,1H,2H,2H-perfluorodecyloxybutenyl-2-O-benzyl-3,4-di-O-carbobenzyl-α-D-
fucopyranoside as a colorless oil, 215.3 mg, 20.7 mmol, 90%). 
Rf: 0.26 (ethyl acetate/hexane/2/3). 
40
1H NMR (CDCl3, 400 MHz): δ (ppm) 7.26 – 7.36 (m, 15H), 5.72 – 5.84 (m, 2H), 5.15 – 
5.23 (m, 6H), 4.44 – 4.81 (m, 4H), 4.05 – 4.23 (m, 6H), 3.66 – 3.78 (m, 1H), 1.15 – 1.27 
(dd, 3H, J = 6.4 Hz). 
13C NMR (CDCl3, 100 MHz): δ (ppm) 155.3, 154.4, 138.1, 135.2, 135.1, 128.9, 128.7, 
128.6, 128.6, 128.6, 128.4, 128.3, 128.3, 128.2, 128.0, 127.8, 127.7 (2), 96.5, 73.3, 75.5, 
74.2, 73.6, 73.5, 70.0, 69.9, 66.4, 64.4, 63.2, 61.9 (2), 26.12), 15.7. 
MS (ESI) m/z = 1061 [M + Na]+ 
O
HO
HO
OH
O
O
C8F17
O
O
OCBz
OCBz
OBn
O
C8F17
 
 
Synthesis of 1H,1H,2H,2H-perfluorodecyloxybutenyl-α-D-fucopyranoside.  
1H,1H,2H,2H-perfluorodecyloxybutenyl-2-O-benzyl-3,4-di-O-carbobenzyl-α-D-
fucopyranoside (81.0 mg, 0.078 mmol) was dissolved in ethanol (3 mL) and 5% Pd/C (20 
mg) was added. The reaction mixture was put under hydrogen atmosphere and stirred 
overnight. It was then filtered over celite and ethanol was removed under reduced pressure 
to give the hydrogenated product in quantitative yield. 
Yield = 100% 
1H NMR (CD3OD, 400 MHz): δ (ppm) 4.15 – 4.31 (m, 1H), 3.45 – 3.98 (m, 11H), 1.62 – 
1.68 (m, 4H), 1.23 (dd, 3H, J = 16.8, 6.4 Hz).   
13C NMR (CD3OD, 100 MHz): δ (ppm) 99.1, 72.3, 70.6, 70.3, 68.6, 67.4, 66.1, 64.3 (2), 
26.1(2), 15.2. 
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MS (ESI) m/z = 705 [M+ Na]+ 
 
C8F17 OH C8F17 OMs 
 
Synthesis of 3-(perfluorooctyl)propanyl methyl sulfonate  
To a solution of 3-(perfluorooctyl)propanol (2.0 g, 4.2 mmol) in dichloromethane (20 mL) 
was added triethylamine (1.20 mL, 8.36 mmol) and the mixture was cooled to 0 °C. Mesyl 
chloride (0.64 mL, 8.4 mmol) was added drop wise over 5 min and the reaction mixture 
was allowed to warm to ambient temperature over 2 h. The reaction mixture was diluted 
with dichloromethane (100 mL) and the organic layer was washed with water (40 mL), 
HCl (2N, 40 mL), and brine (30 mL), and dried over MgSO4. The solvent was removed 
under reduced pressure to provide mesylated product (2.32 g, 100%) as a solid. 
1H NMR (300 MHz, CDCl3): δ 2.05–2.13 (m, 2H), 2.20–2.36 (m, 2H), 3.04 (s, 3H), 4.31 
(t, J = 6 Hz, 2H). 
 
HO OH+C8F17 OMs C8F17 O OH 
 
Synthesis of 4-[3-(perfluorooctyl)propyloxy]-cis-2-butenyl alcohol  
To a solution of cis-1,4-butenediol (0.48 g, 5.4 mmol), 3-(perfluorooctyl)propanyl methyl 
sulfonate (2.3 g, 4.16 mmol), and tetrabutylammonium bromide (0.27 g, 0.83 mmol) in 
DMF (20 mL) was added powdered KOH (0.47 g, 8.32 mmol). The reaction mixture was 
heated at 70 °C for 1 h and then poured into water (20 mL). The aqueous layer was 
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extracted with ethyl acetate (2 mL × 60 mL) and the organic layer was washed with water 
(30 mL) and brine (30 mL), and dried over MgSO4. The solvent was removed under 
reduced pressure. The crude product was purified by flash column chromatography on 
silica gel using 27% EtOAc/hexane as eluent to provide fluorous alcohol (1.57 g, 70%) as 
a yellow oil. 
Rf: 0.64 (ethyl acetate/hexane, 1:1). 
1H NMR (300 MHz, CDCl3): δ (ppm) 1.78–1.88 (m, 2H), 2.04–2.19 (m, 2H), 2.99 (s, 
1H), 3.45 (t, J = 6.0 Hz, 2H), 4.0 (d, J = 6.3 Hz, 2H), 4.13 (d, J = 6.3 Hz, 2H), 5.57–5.65 
(m, 1H), 5.70–5.78 (m, 1H).  
13C NMR (75 MHz, CDCl3): δ (ppm) 20.8, 28.0, 58.4, 66.4, 68.9, 127.9, 132.3. 
 
C8F17 O OH
O
BnO
BnO
BnO
OAc
O
O
C8F17
 
Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside  
To a solution of 2-O-acetyl-3,4,6-tri-O-benzyl-α/β-D-mannopyranosyl trichloroacetimidate 
(370 mg, 0.58 mmol) and 3-(perfluorooctyl)propanyloxybutenyl alcohol (210 mg, 0.38 
mmol) in dichloromethane (4 mL) was added TMSOTf (14 µL, 0.077 mmol) at 5 ºC. The 
reaction mixture was stirred at 5 ºC for 30 min. The reaction mixture was quenched with 
triethylamine (0.05 mL) and then concentrated under reduced pressure. The crude product 
was purified by solid-phase extraction using a fluorous solid-phase extraction cartridge. 
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Nonfluorous compounds were eluted with 80% MeOH/water and the desired product was 
eluted by 100% MeOH. The solvent was removed under reduced pressure to provide 
fluorous-tagged mannose (360 mg, 0.352 mmol, 92%) as viscous yellow oil. 
Rf: 0.74 (ethyl acetate/DCM, 1:9). 
1H NMR (300 MHz, CDCl3): δ (ppm) 1.80–1.88 (m, 2H), 2.11–2.27 (m, 2H) (s, 3H), 3.43 
(t, J = 6.0 Hz, 2H), 3.75–3.92 (m, 4H), 4.01–4.04 (m, 3H), 4.07–4.15 (m, 1H), 4.19–4.26 
(m, 1H), 4.45–4.58 (m, 3H), 4.70 (dd, J = 12.0 Hz, 2H), 4.88 (dd, J = 6.6 Hz, 8.4 Hz, 2H), 
5.35–5.41 (m, 1H), 5.64–5.77 (m, 2H), 7.15–7.36 (m, 15H).  
13C NMR (75 MHz, CDCl3): δ (ppm) 20.1, 61.7, 65.4, 67.6, 67.7, 67.9, 70.5, 70.7, 72.4, 
73.3, 74.2, 77.2, 95.8, 126.6, 126.7, 126.8, 126.8, 126.9, 126.9, 127.0, 127.3, 127.4, 129.3, 
136.9, 137.1, 137.2, 169.4. 
MS (ESI) = 1023 [M+ H]+ 
 
O
BnO
BnO
BnO
OH
O
O
C8F17
O
BnO
BnO
BnO
OAc
O
O
C7F18
 
 
Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside  
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside (360 mg, 0.352 mmol) in methanol (4 mL) was added 0.5 M NaOMe 
(1.4 mL, 0.704 mmol) and the reaction mixture was stirred at ambient temperature for 30 
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min. The crude product was purified by solid-phase extraction by using a fluorous solid-
phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% 
MeOH/water and the desired product was eluted by 100% MeOH. The solvent was 
removed under reduced pressure to provide deacetylated mannose (350 mg, 100%) as 
yellow oil. 
Rf: 0.42 (ethyl acetate/DCM, 1:9). 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.78–1.87 (m, 2H), 2.08–2.23 (m, 2H), 2.53 (s, 
1H), 3.40 (t, J = 6.0 Hz, 2H), 3.68–3.92 (m, 5H), 4.0–4.12 (m, 4H), 4.18–4.24 (m, 1H), 
4.50 (d, J = 10.8 Hz, 1H), 4.53–4.65 (m, 2H), 4.68 (d, J = 2.4 Hz, 2 H), 4.82 (d, J = 10.8 
Hz, 1H), 4.92 (d, J = 1.6 Hz, 1H), 5.60–5.75 (m, 2H), 7.15–7.34 (m, 15H). 
 13C NMR (100 MHz, CDCl3): δ (ppm) 20.8, 28.0, 62.5, 66.4, 68.3, 68.7, 69.0, 71.2, 72.0, 
73.5, 74.3, 75.2, 80.2, 98.3, 127.6, 127.7, 127.8, 128.0, 128.1, 128.3, 128.4, 128.6, 130.2, 
137.9, 138.2. 
MS (ESI) m/z = 981 [M+ H]+ 
 
O
HO
HO
HO
OH
O
O
C8F17
O
BnO
BnO
BnO
OH
O
O
C8F17
 
 
Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-α-D-mannopyranoside  
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside (60 mg, 0.061 mmol) in methanol (3 mL) was added 10% Pd/C (20 mg). 
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The reaction mixture was stirred at ambient temperature under hydrogen atmosphere for 12 
h. The reaction mixture was then filtered over Celite and the solvent was removed under 
reduced pressure to provide fully deprotected mannose (44 mg, 100%) as a solid. 
Rf: 0.75 (methanol/DCM, 1:1). 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.60–1.69 (m, 4H), 1.80–1.89 (m, 2H), 2.18–2.33 
(m, 2H), 3.40–3.88 (m, 12H), 4.74 (m, 1H).  
13C NMR (100 MHz, CD3OD): δ (ppm) 20.8, 26.2, 26.4, 27.6, 61.6, 67.1, 67.4, 68.8, 70.5, 
71.1, 71.4, 73.5, 101.2. 
MS (ESI) m/z = 713 [M+ H]+ 
 
O
O
O
OAc
AcO
AcO
AcO
C8F17
C8F17 O OH
 
 
Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-D-
galactopyranoside  
To a solution of 2,3,4,6-tetra-O-acetyl-α/β-d-galactopyranosyl trichloroacetimidate 
(100 mg, 0.20 mmol) and 3-(perfluorooctyl)propanyloxybutenyl alcohol (3) (75 mg, 
0.14 mmol) in dichloromethane (3 mL) was added TMSOTf (5 µL, 0.027 mmol) at 
−15 °C. The reaction mixture was stirred at −15 °C for 30 min. The reaction mixture was 
quenched with triethylamine (0.5 mL) and then concentrated under reduced pressure. The 
crude product was purified by solid-phase extraction using a fluorous solid-phase 
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extraction cartridge. Nonfluorous compounds were eluted with 80% MeOH/water and the 
desired product was eluted by 100% MeOH. The solvent was removed under reduced 
pressure to provide fluorous-tagged galactose (97 mg, 80%) as a syrup. 
Rf: 0.67 (ethyl acetate/hexane, 1:1). 
1H NMR (400 MHz, CDCl3,): δ (ppm) 1.82–1.89 (m, 2H), 1.95, 2.02, 2.03 (3s, 9H), 2.08–
2.24 (m, 2H) (s, 3H), 3.46 (t, J = 6.0 Hz, 2H), 3.86 (t, J = 5.2 Hz, 1H), 4.01 (t, J = 5.2 Hz, 
1H), 4.10–4.23 (m, 4H), 4.34 (dd, J = 5.6, 10.0 Hz, 1H), 4.75 (d, J = 8 Hz, 1H), 4.99 (dd, 
J = 3.6, 10.4 Hz, 1H), 5.19 (dd, J = 8.0, 10.4 Hz, 1H), 5.36 (d, J = 3.6 Hz, 1H), 5.60–5.76 
(m, 2H).  
13C NMR (100 MHz, CDCl3): δ (ppm) 20.5, 20.6, 20.7, 20.8, 20.9, 61.2, 64.7, 66.5, 67.0, 
68.7, 68.8, 70.7, 70.9, 76.7, 100.1, 127.8, 130.2, 169.4, 170.1, 170.2, 170.3. 
MS (ESI) m/z = 879 [M+ H]+ 
 
O
O
O
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O
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C8F17
 
 
Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-β-D-galactopyranoside  
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-d-
galactopyranoside (97 mg, 0.110 mmol) in methanol (3 mL) was added 5% Pd/C (25 mg). 
The reaction mixture was stirred at ambient temperature under hydrogen atmosphere for 
2 h. The reaction mixture was then filtered over Celite and the solvent was removed under 
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reduced pressure. The product was used directly in the next step. To a solution of 3-
(perfluorooctyl)propanyloxybutanyl-2,3,4,6-tetra-O-acetyl-β-d-galactopyranoside (97 mg, 
0.110 mmol) in methanol (3 mL) was added NaOMe (15 mg) and the reaction mixture was 
stirred at ambient temperature for 2 h. The reaction mixture was neutralized with 
Amberlyst-15 ion-exchange resin and filtered. The solvent was removed under reduced 
pressure to provide fully deprotected galactose (75 mg, 98%) as a solid. 
Rf: 0.70 (methanol/DCM, 1:9). 
1H NMR (300 MHz, CD3OD): δ (ppm) 1.62–1.71 (m, 4H), 1.79–1.87 (m, 2H), 2.11–2.36 
(m, 2H), 3.22–3.34 (m, 1H), 3.41–3.63 (m, 6H), 3.70–3.74 (m, 3H), 3.81–3.99 (m, 2H), 
4.20 (d, J = 6.9 Hz, 1H).  
13C NMR (75 MHz, CD3OD): δ (ppm) 26.1, 26.2, 26.3, 53.3, 61.9, 69.2, 69.3, 69.4, 71.1, 
72.6, 74.1, 76.2, 114.4. 
MS (ESI) m/z = 713 [M+ H]+ 
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Appendix: NMR Spectra 
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Figure 2.1: 1H NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-
D-galactopyranoside. 
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Figure 2.2: 13C NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-
D-galactopyranoside. 
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Figure 2.3: 1H NMR of 1H,1H,2H,2H-perfluorodecyloxybutanyl-β-D-galactopyranoside. 
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Figure 2.4: 13C NMR of 1H,1H,2H,2H-perfluorodecyloxybutanyl-β-D-galactopyranoside. 
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Figure 2.5: 1H NMR of allyl-2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranoside. 
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Figure 2.6: 13C NMR of allyl-2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranoside. 
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Figure 2.6: 1H NMR of 2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranose. 
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Figure 2.7: 13C NMR of 2-O-benzyl-3,4-di-O-carboxybenzyl-α-D-fucopyranose. 
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Figure 2.8: 1H NMR of 2-O-benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranoside 
trichloroacetimidate. 
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Figure 2.9: 13C NMR of 2-O-benzyl-3,4-di-O-carbobenzyl-α/β-D-fucopyranoside 
trichloroacetimidate. 
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Figure 2.10: 1H NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2-O-benzyl-3,4-di-O-
carbobenzyl-α-D-fucopyranoside. 
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Figure 2.11: 13C NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-2-O-benzyl-3,4-di-O-
carbobenzyl-α-D-fucopyranoside. 
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Figure 2.12: 1H NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-α-D-fucopyranoside. 
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Figure 2.13: 13C NMR of 1H,1H,2H,2H-perfluorodecyloxybutenyl-α-D-fucopyranoside. 
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Figure 2.14: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6-tri-O-
benzyl-α-D-mannopyranoside. 
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Figure 2.15: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6-tri-O-
benzyl-α-D-mannopyranoside. 
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Figure 2.16: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside. 
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Figure 2.17: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside. 
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Figure 2.18: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-α-D-mannopyranoside. 
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Figure 2.19: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-α-D-mannopyranoside. 
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Figure 2.20: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-
D-galactopyranoside. 
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Figure 2.21: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-2,3,4,6-tetra-O-acetyl-β-
D-galactopyranoside. 
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Figure 2.22: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-β-D-galactopyranoside. 
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Figure 2.23: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-β-D-galactopyranoside. 
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CHAPTER 3: FLUOROUS-TAG ASSISTED SOLUTION 
PHASE SYNTHESIS OF MANNOSE OLIGOSACCHARIDES 
AND GLYCERO-D-MANNO HEPTOSES 
 
Introduction 
The emerging understanding of the critical role of oligosaccharides in biological processes 
and the promise of therapeutics based on oligosaccharides create an urgent need for an 
efficient synthetic methodology for oligosaccharides. In spite of the achievements in the 
chemical synthesis of oligosaccharides based on the development of highly reactive sugar 
donors (Schmidt 1986, 1994), glycosylation strategies and advanced protective group 
chemistry in recent years (Schmidt 1992, Ogawa 1994, Barresi 1995), one of the future 
tasks is to combine this knowledge with the advantages of the solid phase synthesis and 
support glycobiology studies with a variety of well defined oligosaccharides and 
glycoconjugates. 
Oligosaccharides of D-mannose (Figure 3.1) are found in nature as essential substructures 
of many bioactive glycoconjugates, such as N-glycans, fungal cell wall mannans 
(Kobayashi 1992) and GPI anchors (Pekari 2001), and as high affinity ligands for various 
mannose binding proteins, for example, Con A (Sanders 2001) and Cyanovirin N (Botos 
2002). 
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Figure 3.1. High-mannose oligosaccharide targets 
 
Several research groups have developed very effective strategies for the conventional step-
wise solution synthesis of manno-oligosaccharides (Ogawa 1981, 1985, 1986, Ning 1999, 
Zhu 2000, Zheng 2003, Grice 1995, 1996, Green 1998, Mayer 1994, Ratner 2002). High 
yields were achieved in relatively short reaction sequences from monosaccharide building 
blocks by prudent choice of protecting groups and/or fine-tuning of mannosyl donors. Such 
syntheses, involving selective protection, followed by glycosylation and deprotection 
sequences, are nevertheless time consuming, as they require chromatographic purification 
of all intermediates. Over the last two decades efforts have been made to develop protocols 
for the construction of oligosaccharides on polymer supports (Osborne 1995, Krepinsky 
2000, Seeberger 2000, Sears 2001) that simplify the isolation and purification of 
intermediates, since nonsupported reagents can be removed merely by washing the 
insoluble products with suitable solvents. Chromatography is required only once, after 
cleavage of the end product from the support. The automation of oligosaccharide synthesis 
has lagged decades behind those of the oligopeptides and oligonucleotides, but significant 
developments have now been reported (Sears 2001, Plante 2003). 
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In spite of its considerable merits, progress in polymer supported oligosaccharide synthesis 
has, on the whole, been slow because glycosidic bond formation does not, in general, 
proceed with the high yield and stereoselectivity necessary for successful application of 
this technique. α-Mannosylation is one of the few exceptions, and the polymer supported 
synthesis of α-linked oligomannosides has therefore seemed a feasible alternative to 
classical solution synthesis. Thus, α-(1→2)-linked manno-tri- (Rademan 1997), tetra- 
(Rademan 1997), hexa- (Grathwohl 2001) and hepta (Andrade 1999) -ose derivatives have 
been prepared on Merrifield’s resin with isolated yields of cleaved products of 54%, 34%, 
19% and 9%, respectively, and when syntheses of such compounds were carried out under 
automation, higher yields were achieved (Plante 2003). 
A distinct disadvantage of synthesis on the most common, insoluble supports, for example, 
polystyrene resins or controlled-pore glass, is the difficulty of monitoring the progress of 
reactions. This problem can be overcome by the use of soluble polymer supports, in 
particular polyethylene glycol ω-monomethyl ether [HOCH2-CH2(OCH2CH2)nOMe 
(MPEG)], introduced by Krepinsky and co-workers (Douglas 1995, Krepinsky 2001). 
As core structures, the 3,6-branched trimannosaccharide unit (Manαl-6Man3-lαMan) and 
pentamannoside unit [(Manαl-6Man3-lαMan)αl-6Man3-lαMan)] is widely expressed on a 
lot of glycoproteins. They exist in all asparagines-linked oligosaccharides (N-glycans) and 
the major Con A binding epitope on oligosaccharide-type carbohydrate (Wang 1999). 
Recently, it has been shown that these core trisaccharide and pentasaccharide is highly 
expressed on gp120 of HIV (Figure 3.2) (Hadar 2001). It is selectively bound to DC-SIGN, 
leading to the HIV migration from mucous membrane to the lymph system (Carole 2002). 
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Consequently, the syntheses of these core trisaccharide and pentasaccharide are of great 
interest (Zhang 2002). 
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Figure 3.2 3- and 6-Modified branched mannose oligosaccharides. 
 
Structurally complex lipopolysaccharides (LPS) are amphipathic and microheterogeneous 
glycolipids and essential components of the outer membrane of Gram-negative bacteria 
(Raetz 2002). LPS mediate numerous immunological and pathophysiological effects in 
bacterial infections. The L-glycero-D-manno- and D-glycero-D-manno-heptoses, are 
common constituents of both the inner- and outer-core regions of LPS of many pathogenic 
bacteria, where they are present mostly in the α-anomeric configuration (Zamyatina 2003). 
The synthesis of higher-carbon sugars such as heptoses has been investigated for more than 
a century (Györgydeák 1998), and several methods have been developed (Györgydeák 
1998, Zamyatina 2003). The synthesis of a large number of complex oligosaccharides 
containing α-L,D- or α-D,D-heptopyranosides (Hepp), has been achieved by Oscarson and 
co-workers (Oscarson 1994, Ekeloef 1995, Bernlind 1998, Oscarson 2001, Segerstedt 
2004). Due to the increasing resistance of many bacterial strains against conventional 
antibiotics, a detailed understanding of the immunological responses is necessary in order 
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to develop novel drugs, which may prevent the assembly of a functionally intact bacterial 
cell wall by inhibition of its biosynthesis (Zamyatina 2003).  
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Figure 3.3. Structure of α-(1→2)-linked heptomannose oligosaccharides. 
 
Thus, well-defined syntheses of complex oligosaccharides and glycoconjugates 
corresponding to the native bacterial structures are essential, as the synthetic derivatives 
can be employed to (i) locate immunodominant motifs, (ii) determine the specificity of the 
antibody response obtained from native structures, and (iii) investigate the processing of 
glycoproteins by the immune systems. Here, we describe the synthesis of fluorous-tagged 
L-glycero-D-manno- and D-glycero-D-manno-heptoses to study the binding interactions of 
these seven carbon sugars with mannose binding lectin, Con A. Con A has been widely 
used to identify mannose containing ligands. By replacing one of the hydrogen at C-6 
position of mannose with a CH2OH, a heptomannose is obtained. It will be interesting to 
know whether Con A will bind to heptomannose compounds. 
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Results and Discussion 
There are several methods reported in literature for the synthesis of oligosaccharides. The 
most common method is the solution phase synthesis but it is very tedious and time 
consuming. Solution phase synthesis does not provide access of oligosaccharides to 
nonchemists. Application of solid-phase chemistry to carbohydrates provided access to 
complex oligosaccharides. As discussed in the introduction chapter, the major drawback of 
SPOS is the use of excess donor during coupling cycle to drive the reaction to completion. 
To circumvent this problem, Hindsgaul and coworkers came up with a novel method of 
combining solution-phase and solid-phase chemistry (Hindsgaul 1995). Rademann took 
this approach to a new level by developing hydrophobically assisted switching phase 
synthesis (HASP) of oliogosaccharides (Bauer 2005). It has huge promise for the synthesis 
of oligosaccharides. But like other methods, this does not provide direct access for the 
fabrication of carbohydrate microarrays to study protein-carbohydrate interactions. 
We have already discussed the use of fluorous support for oligosaccharide synthesis and 
direct micrarray formation. In order to test if we can extend this method to the synthesis of 
polysaccharides, we decided to apply this method for the synthesis of linear α-(1→2)-
linked mannose oligosaccharides and 3, 6-modified branched mannose oligosaccharides. 
Linear α-(1→2)-linkages in mannose oligosaccharides is easy to make and hence would be 
a good starting point to test the power of this method. It will further test the scope of 
fluorous-based carbohydrate microarrays to study the binding of several mannose 
oligosacharides with mannose binding lectin Con A. Concanavallin A (Con A), is a lectin 
isolated from jack bean meal, has been reported to bind with non-reducing α-D-glucose 
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and α-D-mannose. Inhibition data suggest that unmodified hydroxyl groups at the C-3, C-
4, and C-6 positions of the D-mannopyranose (Goldstein 1965). 
As mentioned in the previous chapter, fluorous support could be used for the synthesis of 
complex oligosaccharides and has all advantages of solid-phase synthesis. The fluorous-
tagged compounds can be easily separated from the non-fluorous compounds by passing 
the crude product through fluorous solid-phase extraction (FSPE) column and it is 
amenable to automation. All glycosylations and protective group manipulations clearly 
should be compatible with the fluorous linker. The chain was elongated from the reducing 
end (i.e. the terminal sugar residue whose C-l oxygen atom is not conneced to another 
sugar residue) to the non-reducing end (i.e. a terminal residue that is connected to other 
parts of the oligosaccharide chain via its C-l oxygen atom). Linear α(1→2)-linked mannose 
tetrasaccharide was synthesized using fluorous support. All intermediates were purified 
using FSPE column only. 
 
Synthesis of Mannose Oligosaccharides 
The mannose trichloroacetimidate donor 3.5 was chosen as the donor building block 
because it can be prepared on a multigram scale, is activated at room temperature, and 
bears a C2-ester functionality to control the anomeric configuration of the fluorous linker. 
Initial experiments on coupling of the fluorous linker 3.4 with mannose donor 3.5 resulted 
in the formation of fluorous-tagged mannose 3.6 and some transacetylation product 3.9 
(Scheme 3.1). It is reported in the literature that transacetylation is a very common side 
product in glycosylation reactions. It is proposed that the transacetylaed product is formed 
via orthoester formation (Scheme 3.1). The following solutions have been provided to 
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avoid the formation of transacetylation product: 1) use of pivaloyl group and 2) run the 
reactions concentrated. We chose to apply the second solution to our glycosylation reaction 
and found that the glycosylation reaction worked well and no transacetylation product was 
observed. Deprotection of temporary acetyl group with NaOMe/MeOH produced 
compound 3.7 in 98% yield. 
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Scheme 3.1 Glycosylation of fluorous linker with mannose trichloroactimidate donor. 
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Scheme 3.2 Synthesis of mannose tetrasaccharide in a manner to mimic automated 
synthesizer. 
 
Glycosylation and deprotection steps were repeated to obtain di-, tri- and tetrasaccharides 
respectively (Scheme 3.2). The HPLC trace of all the compounds obtained after FSPE 
purification shows high purity in these reactions. 
After successfully achieving the synthesis of linear mannose tetrasaccharide, we put our 
attention towards synthesizing branched mannose oligosaccharides.  To extend the scope 
of this method, we chose two 3- and 6-modified branched mannose oligosaccharides 
(Figure 3.2). 
To synthesize the building block for 3- and 6-modified mannose oligosaccharides, various 
combinations of protecting groups were explored based on their orthogonality.   It is 
reported in the literature that acetyl group can be selectively removed in presence of 
pivaloyl. We designed a scheme where we used acetyl group at 3-position and pivaloyl at 
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2-postion to construct the desired linkages (Scheme 3.3). Since equatorial hydroxyl group 
is more acidic than axial, the 3-position hydroxyl group in compound 3.14 was selectively 
acetylated. Compound 3.17 was obtained after performing standard protection and 
deprotection steps. At this stage 6-position hydroxyl group was selectively silylated with 
TBDPSCl to give compound 3.18. Acid-catalyzed benzylation, microwave-assisted 
cleavage of allyl group followed by trichloroacetimidate reaction gave the desired sugar 
donor 3.21. 
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Scheme 3.3 Synthesis of donor for 3, and 6-modified mannose oligosaccharides. 
 
Now glycosylation of fluorous alcohol with donor 3.21 was performed in dichloromethane 
using catalytic amount of TMSOTf (Scheme 3.4). The coupling reaction worked well 
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resulting in 95% yield of the glycosylated product. The product was purified by passing 
through FSPE column. Deprotection of TBDPS group with 1 M TBAF gave compound 
3.23 in 70% yield. Recently Seeberger reported the synthesis of Leishmania cap 
tetrasaccharide where he selectively deprotects acetyl group in the presence of pivaloyl 
using NaOMe/MeOH. These conditions were tried on compound 3.23 to get selective 
deacetylation but after only 30 min the reaction resulted in the cleavage of both acetyl and 
pivaloyl group. 
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Scheme 3.4 Synthesis of fluorous-tagged 3- and 6-modified mannose oligosaccharide. 
 
Numerous attempts to selectively remove acetyl group using Mg(OMe)2, guanidine, and 
AcCl/MeOH were unsuccessful. So we decided to change the protecting group at 3-
position to levulinyl (Scheme 3.5). Selective protection of 3-position hydroxyl group with 
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levulinic acid resulted in compound 3.25 in 90% yield as a mixture of anomers. 
Pivaloylation of 2-position hydroxyl group produced compound 3.26 in 75% yield. 
Cleavage of benzylidine followed by selective protection of 6-position hydroxyl group 
with TBDPS gave compound 3.28. Benzylation at 4-position, deprotection of allyl group 
followed by trichloroacetimidate reaction produced the desired mannose donor 3.31 in 
good yield.  
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Scheme 3.5 A new 3- and 6-modified mannose donor. 
 
Coupling of the new donor and fluorous alcohol was performed as described earlier. The 
resulting product 3.32 was desilylated with 1 M TBAF to produce compound 3.33 in 70% 
yield. Treatment of compound 3.33 with NH2NH2 (1 M in pyridine/acetic acid, 3:2) in 
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pyridine for 30 min gave the desired product 3.34 in 95% yield. Coupling of fluorous-
tagged mannose 3.34 with mannose trichloroactimidate 3.5 gave trimannoside 3.35 in 92% 
yield (Scheme 3.6). 
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Scheme 3.6 Synthesis of 3,6-branched trimannosaccharide unit. 
 
Mannose donor 3.31 was also used to synthesize pentamannoside (Scheme 3.7). Fluorous-
tagged mannose 3.33 was coupled with another mannose unit to make mannose α-(1→6)-
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disaccharide 3.36. Removal of 6-position TBDPS followed by deprotection of two 
levulinyl groups gave compound 3.38. Tri-glycosylation of compound 3.38 with mannose 
trichloroacetimidate 3.5 resulted in the formation of mannose pentasaccharide 3.39 in 90% 
yield. 
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Scheme 3.7 Synthesis of pentamannoside. 
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 Deprotection of acetyl and pivaloyl groups followed by global deprotection of benzyl 
groups resulted in the formation of fully deprotected fluorous-tagged linear and branched 
mannose oligosaccharides (Scheme 3.8). 
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 Scheme 3.8 Synthesis of fully deprotected linear and branched oligosaccharides.  
Synthesis of Heptomannose 
In order to synthesize both diastereomers of fluorous-tagged heptomannose compounds, 
we found several methods in the literature (Gurjar 2004, Van Boom 1989, Oscarson 2000, 
Crich 2005). We approached the synthesis of heptomannose building block using the 
method published by Crich and coworkers that gives a mixture of D-glycero-D-manno 
heptose and L-glycero-D-manno heptose in 3:1 ratio.  The principal disconnections for the 
retrosynthetic analysis used are illustrated in figure 3.4. 
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Figure 3.4 Retrosynthetic analysis for D-glycero-D-manno heptose and L-glycero-D-
manno heptose. 
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Trichloroacetimidate 1 could be obtained from orthoester 2 by opening of the orthoester, 
separation of diastereomers followed by trichloroacetimidate formation. Compound 2 
could be made by benzylation of compound 3. The key reaction in this strategy is 
dihydroxylation of compound 4 to obtain compound 3 as a mixture of diastereomers. 
Compound 4 could be obtained by Wittig reaction of aldehyde 5, which could be made 
from D-mannose via orthoester 6. 
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Scheme 3.9 Synthesis of D-glycero-D-manno heptopyranoside and L-glycero-D-manno 
heptopyranoside donors. 
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Compound 3.40 was synthesized from D-mannose in seven steps and 65% overall yield 
(Scheme 3.9). Various methods like PCC, Swern, Parikh-Doering were tried for the 
oxidation of 6-position hydroxyl groups but they all gave poor yield of the desired 
aldehyde. Dess-Martin reagent used for the oxidation gave good yield of the desired 
aldehyde. The crude aldehyde was used directly for Wittig reaction to give alkene 3.41 in 
90% yield over two steps.  Osmylation of alkene 3.41 gave a 3:1 mixture of diasteromers 
in favor of R configuration at the newly generated stereocenter, which is in accordance 
with Kishi’s empirical rule. Benzylation of compound 3.42 followed by the opening of 
orthoester resulted in compounds 3.44 and 3.45 respectively. These two compounds were 
converted to the corresponding trichloroacetimidate donors 3.46 and 3.47 respectively. 
To verify the stereochemistry of the major diastereomer 3.44, it was converted into the 
known compound 3.48 {[α]D = +22.2 (c 0.9, CHCl3); lit. (Gurjar 2004) [α]D = +22.5 (c 0.9, 
CHCl3)} (Scheme 3.10). These studies indirectly ensured the stereochemical assignment of 
compound 3.45 as indicated. 
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Scheme 3.10 Confirmation of stereochemistry at C-6 position. 
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Scheme 3.11 Synthesis of fluorous-tagged D-glycero-D-manno heptopyranoside and L-
glycero-D-manno heptopyranoside. 
 
Next step was to try glycosylation to make fluorous-tagged heptomannose compounds. 
Both the donors were separately coupled with fluorous alcohol 3.4 to produce the desired 
fluorous-tagged heptomannose compounds (Scheme 3.11). To show that the chain could be 
elongated to make disaccharide, compound 3.48 was deacetylated and coupled with 
another heptomannose donor 3.46 to make linear α-(1→2) heptomannose disaccharide 
(Scheme 3.12).  
92
OBnO
BnO
OH
BnO
BnO
O
O
C8F17
OBnO
BnO
OAc
BnO
BnO
O
NH
CCl3
1. TMSOTf, CH2Cl2, 5 °C,
15 min
OBnO
BnO
O
BnO
BnO
O
O
C8F17
OBnO
BnO
OH
BnO
BnO
2. 0.5 M NaOH, MeOH,
rt, 30 min, 96%
Pd/C, MeOH, H2,
rt, 26 h, 96% OHO
HO
O
HO
HO
O
O
C8F17
OHO
HO
OH
HO
HO
3.49 3.50 3.51
3.46
 
Scheme 3.12 Synthesis of Heptomannose disaccharide. 
 
Deprotection of acetyl groups followed by global deprotection to remove benzyl groups 
resulted in the formation of fully deprotected fluorous-tagged heptomannose compounds 
3.52 and 3.53 respectively (Scheme 3.13). 
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Scheme 3.13 Synthesis of fully deprotected fluorous-tagged heptomannose. 
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Carbohydrate Microarrays 
We have reported earlier that monosaccharides and disaccharides can be successfully 
immobilized on the fluorous-coated glass slides. Now we focused our attention to 
immobilize higher oligomers such as trisaccharides, tetrasaccharides, etc. onto a fluorous-
coated glass slide and study their binding with Con A. Con A, the mannose-specific lectin 
has long been used as a model for carbohydrate-protein interactions. Its commercial 
availability and knowledge of 3D structure make it attractive for assessing and optimizing 
the functional parameters that affect its affinity for mannose. Understanding these key 
elements may facilitate the development of new therapeutic strategies based on specific 
recognition events such as targeting of drugs.  
Fluorous-tagged mannose oligosaccharides and heptomannose monosaccharides and 
disaccharide were spotted onto a fluorous-coated glass slide using a microarrayer. The 
glass slide was dried and then incubated with FITC labeled Con A containing 1% BSA for 
30 min. The glass slide was then washed with HEPES buffer containing 0.05% TWEEN-
20, dried for 30 min in a dark chamber. The glass slide was scanned with a laser at 488 nm. 
The results of the scans are shown in figure 3.4. 
 
 
Figure 3.4 Scan of fluorous-tagged carbohydrate microarray incubated with FITC-labeled 
Con A at 488 nm (Data provided by Dr. Beatrice Collet). 
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It is evident from the scan that the noncovalent fluorous-fluorous interactions are strong 
enough to retain higher oligomers of mannose onto the glass slide. The most important 
information revealed from this experiment is that seven-carbon mannose also binds to Con 
A that was not known previously.  
 
Conclusions 
In summary a library of fluorous-tagged mannose and heptomannose oligosaccharides 
were synthesized using a C8F17 fluorous support. Fluorous support was used in a manner as 
to mimic automated synthesis of oligosaccharides. Separation of fluorous-tagged 
compounds from non-fluorous was performed by simple passing the reaction mixture 
through fluorous solid-phase extraction column (FSPE). Direct formation of microarrays of 
the higher mannose oligosaccharides and heptomannose mono- and di-saccharides to test if 
noncovalent fluorous-fluorous interactions are strong enough to retain higher oligomers of 
mannose onto the glass slide were fruitful. The study of binding interactions between both 
diastereomers of glycero-D-manno-heptoses and Con A revealed that Con A has affinity 
towards C-6 modified mannose.  
 
Experimental  
All reagents were purchased from Aldrich. Dichloromethane was distilled over calcium 
hydride THF and toluene was used from solvent purification towers. Amberlyst 15 ion-
exchange resin was washed repeatedly with methanol before use. All other commercial 
reagents and solvents were used as received without further purification. The reactions 
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were monitored and the Rf values determined using analytical thin layer chromatography 
(tlc) with 0.25 mm EM Science silica gel plates (60F-254). The developed TLC plates 
were visualized by immersion in p-anisaldehyde solution followed by heating on a hot 
plate. Flash chromatography was performed with Selecto Scientific silica gel, 32-63 µm 
particle sizes. Fluorous phase chromatography was performed using fluorous solid-phase 
extraction cartridges containing silica gel bonded with perfluorooctylethylsilyl chains 
(Fluorous Technologies Inc.; Pittsburgh, PA). All other Fluorous reagents were also 
obtained from Fluorous Technologies, Inc. All moisture-sensitive reactions were 
performed in flame- or oven-dried glassware under a nitrogen atmosphere. Bath 
temperatures were used to record the reaction temperature in all cases run without 
microwave irradiation. All reactions were stirred magnetically at ambient temperature 
unless otherwise indicated.  
 
1H NMR and 13C NMR spectra were obtained with a Bruker DRX400 and Varian 
VXR300. 1H NMR spectra were reported in parts per million (δ) relative to CDCl3 (7.27 
ppm) or CD3OD (4.80) as an internal reference. 13C NMR spectra were reported in parts 
per million (δ) relative to CDCl3 (77.23 ppm) or CD3OD (49.15 ppm). A Shimadzu LCMS 
2010 quadrupole mass spectrometer (Shimadzu Scientific Instruments, Columbia, MD) 
equipped with and electronspray ionization (ESI) source was used in positive ion mode. 
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 Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-O-
acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-α-D-
mannopyranoside (150 mg, 0.153 mmol) and 2-O-acetyl-3,4,6-tri-O-benzyl-α/β-D-
mannopyranosyl trichloroacetimidate (146 mg, 0.229 mmol) in dichloromethane (3 mL) 
was cooled to 5 ºC and TMSOTf (6 µL, 0.031 mmol) was added. The reaction mixture was 
stirred for 30 min. The reaction mixture was quenched with triethylamine (30 µL) and then 
concentrated under reduced pressure. The crude product was purified by solid-phase 
extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to obtain mannose 
disaccharide (214 mg, 0.147 mmol, 96%) as a yellow gel. 
Rf: 0.77 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.79-1.86 (m, 2 H), 2.09-2.21 (m, 2 H), 2.16 (s, 3 
H), 3.38 (t, 2 H, J = 6 Hz), 3.71-4.21 (m, 14 H), 4.43-4.70 (m, 12 H), 4.88 (dd, 1 H, J = 
3.6, 10.8 Hz), 4.94 (s, 1 H), 5.11 (s, 1 H), 5.57 (s, 1 H), 5.62-5.69 (m, 2 H), 7.16-7.36 (m, 
30 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.87, 21.27, 28.06, 62.77, 66.54, 68.72, 68.79, 
62.84, 69.49, 69.57, 71.95, 71.97, 72.01, 72.19, 72.31, 73.32, 73.40, 73.44, 73.54, 74.31, 
74.81, 74.91, 74.99, 75.04, 75.15, 75.22, 75.27, 77.35, 78.21, 79.62, 98.21, 100.74, 127.53, 
127.55, 127.58, 127.61, 127.64, 127.68, 127.71, 127.77, 127.85, 127.93, 128.02, 128.06, 
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128.14, 128.17, 128.26, 128.30, 128.32, 128.34, 128.39, 128.42, 128.43, 128.51, 129.77, 
138.11, 138.25, 138.34, 138.41, 138.44, 138.45, 138.52, 138.59, 138.62, 170.25. 
MS (ESI): 1477 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(2-O-
acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-
mannopyranosyl]-α-D-mannopyranoside 
 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-
benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside (150 mg, 0.106 mmol) and 2-O-
acetyl-3,4,6-tri-O-benzyl-α/β-D-mannopyranosyl trichloroacetimidate (101 mg, 0.159 
mmol) in dichloromethane (3 mL) was cooled to 5 ºC and TMSOTf (4 µL, 0.021 mmol) 
was added. The reaction mixture was stirred for 30 min. The reaction mixture was 
quenched with triethylamine (30 µL) and then concentrated under reduced pressure. The 
crude product was purified by solid-phase extraction by using a Fluorous solid-phase 
extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% MeOH/water 
and the desired product was eluted by 100% MeOH. The solvent was removed under 
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reduced pressure to obtain mannose trisaccharide (189 mg, 0.100 mmol, 94%) as a yellow 
gel. 
Rf: 0.79 (EtOAc/hexane, 1/1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.79-1.86 (m, 2 H), 2.05-2.21 (m, 2 H), 2.15 (s, 3 
H), 3.37 (t, 2 H, J = 6 Hz), 3.55 (d, 1 H, J = 10.8 Hz), 3.65-4.02 (m, 17 H), 4.13-4.17 (m, 2 
H), 4.33 (d, 1 H, J = 12 Hz), 4.43-4.72 (m, 14 H), 4.83-4.90 (m, 3 H), 4.97 (s, 1 H), 5.08 
(s, 1 H), 5.23 (s, 1 H), 5.26 (s, 1 H), 5.57 (s, 1 H), 5.62-5.65 (m, 2 H), 7.17-7.35 (m, 45 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.87, 21.27, 28.06, 62.77, 66.54, 68.72, 68.79, 
62.84, 69.49, 69.57, 71.95, 71.97, 72.01, 72.19, 72.31, 73.32, 73.40, 73.44, 73.54, 74.31, 
74.81, 74.91, 74.99, 75.04, 75.15, 75.22, 75.27, 77.35, 78.21, 79.62, 98.21, 100.74, 127.53, 
127.55, 127.58, 127.61, 127.64, 127.68, 127.71, 127.77, 127.85, 127.93, 128.02, 128.06, 
128.14, 128.17, 128.26, 128.30, 128.32, 128.34, 128.39, 128.42, 128.43, 128.51, 129.77, 
138.11, 138.25, 138.34, 138.41, 138.44, 138.45, 138.52, 138.59, 138.62, 170.25. 
MS (ESI): 1909 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(2-O-
(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)3,4,6-tri-O-benzyl-α-D-
mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-α-D-mannopyranoside 
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A solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(3,4,6-
tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-α-D-
mannopyranoside (150 mg, 0.081 mmol) and 2-O-acetyl-3,4,6-tri-O-benzyl-α/β-D-
mannopyranosyl trichloroacetimidate (77 mg, 0.122 mmol) in dichloromethane (3 mL) was 
cooled to 5 ºC and TMSOTf (3 µL, 0.016 mmol) was added. The reaction mixture was 
stirred for 30 min. The reaction mixture was quenched with triethylamine (30 µL) and then 
concentrated under reduced pressure. The crude product was purified by solid-phase 
extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to obtain mannose 
trisaccharide (183 mg, 0.079 mmol, 97%) as a yellow gel. 
Rf: 0.80 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.78-1.86 (m, 2 H), 2.05-2.21 (m, 2 H), 2.15 (s, 3 
H), 3.36 (t, 2 H, J = 5.6 Hz), 3.49-3.79 (m, 11 H), 3.85-4.02 (m, 14 H), 4.12-4.19 (m, 4 H), 
4.35 (d, 1 H, J = 2.4 Hz), 4.37 (d, 1 H, J = 3.2 Hz), 4.39-4.89 (m, 22 H), 4.99 (s, 1 H), 5.07 
(s, 1 H), 5.20 (s, 1 H), 5.26 (d, 1 H, J = 3.6 Hz), 5.57-5.66 (m, 3 H), 7.17-7.38 (m, 60 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.81, 21.28, 29.79, 62.77, 66.54, 68.70, 68.75, 
69.52, 69.56, 69.65, 71.62, 71.80, 71.87, 71.96, 71.99, 72.22, 72.34, 73.33, 73.43, 73.55, 
74.35, 74.75, 74.91, 75.04, 75.15, 75.23, 75.30, 75.58, 77.34, 78.24, 79.48, 98.21, 99.49, 
100.85, 101.27, 127.27, 127.52, 127.54, 127.60, 127.64, 127.67, 127.73, 127.77, 127.82, 
127.93, 128.03, 128.12, 128.22, 128.26, 128.31, 128.37, 128.38, 128.41, 128.51, 128.64, 
128.70, 129.69, 138.13, 138.21, 138.37, 138.41, 138.44, 138.48, 138.50, 138.56, 138.61, 
138.68, 170.22. 
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MS (ESI): 2341 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(α-D-mannopyranosyl)-α-D-
mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-O-
acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside (200 mg, 0.138 
mmol) in methanol (4 mL) was added 0.5 M NaOMe (0.55 mL, 0.276 mmol) and the 
reaction mixture was stirred at ambient temperature for 30 min. The crude product was 
purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide deacetylated mannose (195 mg, 0.138 mmol, 100%) as yellow oil. To a solution of 
3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-O-acetyl-3,4,6-tri-O-
benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside (195 mg, 0.138 mmol) in methanol 
(3 mL) was added 10% Pd/C (60 mg). The reaction mixture was stirred at ambient 
temperature under hydrogen atmosphere for 24 h. The reaction mixture was then filtered 
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over Celite and the solvent was removed under reduced pressure to provide (121 mg, 0.138 
mmol, 100%) as a white solid. 
Rf: 0.68 (methanol/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.60-1.65 (m, 4 H), 1.78-1.86 (m, 2 H), 2.14-2.29 
(m, 2 H), 3.45-3.79 (m, 17 H), 3.95 (s, 1 H), 4.93 (s, 1 H), 5.03 (s, 1 H).  
13C NMR (100 MHz, CD3OD): δ (ppm) 19.11, 20.50, 25.96, 26.23, 61.68, 66.99, 67.42, 
67.67, 68.73, 70.34, 70.50, 70.83, 71.01, 73.24, 73.30, 73.63, 79.35, 98.55, 102.83.   
MS (ESI): 875 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(α-D-mannopyranosyl)-
α-D-mannopyranosyl]-α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(2-O-
acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-
α-D-mannopyranoside (200 mg, 0.106 mmol) in methanol (4 mL) was added 0.5 M 
NaOMe (0.42 mL, 0.212 mmol) and the reaction mixture was stirred at ambient 
temperature for 30 min. The crude product was purified by solid-phase extraction by using 
a fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted 
with 80% MeOH/water and the desired product was eluted by 100% MeOH. The solvent 
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was removed under reduced pressure to provide deacetylated mannose (196 mg, 0.106 
mmol, 100%) as yellow oil. To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-
tri-O-benzyl-2-O-[2-O-(3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-
mannopyranosyl]-α-D-mannopyranoside (196 mg, 0.106) in methanol (3 mL) was added 
10% Pd/C (60 mg). The reaction mixture was stirred at ambient temperature under 
hydrogen atmosphere for 30 h. The reaction mixture was then filtered over Celite and the 
solvent was removed under reduced pressure to provide (110 mg, 0.106 mmol, 100%) as a 
white solid. 
Rf: 0.63 (methanol/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.60-1.65 (m, 4 H), 1.78-1.86 (m, 2 H), 2.14-2.25 
(m, 2 H), 3.45-3.84 (m, 22 H), 3.95 (s, 1 H), 4.01 (s, 1 H), 4.95 (s, 1 H), 5.03 (s, 1 H), 5.25 
(s, 1 H).  
13C NMR (100 MHz, CD3OD): δ (ppm) 20.50, 25.97, 26.23, 61.65, 61.75, 61.90, 67.01, 
67.41, 67.66, 67.86, 68.73, 70.34, 70.51, 70.55, 70.83, 71.04, 73.25, 73.60, 78.95, 79.49, 
98.51, 101.12, 102.70.   
MS (ESI): 1037 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(2-O-(α-D-
mannopyranosyl)-α-D-mannopyranosyl)-α-D-mannopyranosyl]-α-D-
mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(2-O-
(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)3,4,6-tri-O-benzyl-α-D-
mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-α-D-mannopyranoside (200 
mg, 0.086 mmol) in methanol (4 mL) was added 0.5 M NaOMe (0.34 mL, 0.172 mmol) 
and the reaction mixture was stirred at ambient temperature for 30 min. The crude product 
was purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide deacetylated mannose (195 mg, 0.086 mmol, 100%) as yellow oil. To a solution of 
3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-O-(2-O-(3,4,6-tri-O-
benzyl-α-D-mannopyranosyl)3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-
α-D-mannopyranosyl]-α-D-mannopyranoside (195 mg, 0.086 mmol) in methanol (3 mL) 
was added 10% Pd/C (60 mg). The reaction mixture was stirred at ambient temperature 
under hydrogen atmosphere for 30 h. The reaction mixture was then filtered over Celite 
and the solvent was removed under reduced pressure to provide (103 mg, 0.086 mmol, 
100%) as a white solid. 
Rf: 0.58 (methanol/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.60-1.65 (m, 4 H), 1.80-1.86 (m, 2 H), 2.16-2.25 
(m, 2 H), 3.32 (s, 2 H), 3.44-3.79 (m, 26 H), 3.95-3.99 (m, 2 H), 4.96 (s, 1 H), 5.03 (s, 1 
H), 5.25 (s, 1 H).  
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13C NMR (100 MHz, CD3OD): δ (ppm) 12.88, 20.50, 25.97, 26.23, 27.24, 27.45, 27.64, 
48.49, 60.05, 61.64, 61.86, 61.95, 67.02, 67.31, 67.67, 67.83, 68.73, 70.34, 70.51, 70.55, 
70.84, 71.03, 73.26, 73.57, 73.64, 78.82, 79.09, 79.49, 98.50, 101.02, 102.67.   
MS (ESI): 1199 (M+H)+ 
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Synthesis of Allyl-3-O-acetyl-4,6-O-benzylidene-2-hydroxy-α-D-mannopyranoside 
Allyl-4,6-O-benzylidene-2,3-di-O-hydroxy-α/β-D-mannopyranoside (5.18 g, 16.8 mmol) 
was dissolved in dichloromethane (60 mL) and cooled to –15 ºC and pyridine (2.0 mL, 
25.2 mmol) was added followed by acetyl chloride (1.32 mL, 18.5 mmol). The reaction 
mixture was stirred at –15 ºC for 1 h and quenched with water. The aqueous layer was 
extracted with dichloromethane (2 x 100 mL). The combined organic layer was washed 
with HCl (2N, 50 mL), brine (50 mL) and dried over sodium sulfate. The solvent was 
removed under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel using 38% ethyl acetate/hexane to give the desired product as 
α-anomer (3.21 g, 9.17 mmol, 55%). 
Rf: 0.37 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CD3OD):  δ (ppm) 2.08 (s, 3 H), 2.76 (br s, 1 H), 3.79-3.84 (m, 1 H), 
3.91-4.00 (m, 2 H), 4.05-4.11 (m, 2 H), 4.15-4.4.20 (m, 1 H), 4.24 (dd, 1 H, J = 4.4, 10 
105
Hz), 4.84 (s, 1 H), 5.20 (d, 1 H, J = 10.4 Hz), 5.26-5.33 (m, 2 H), 5.52 (s, 1 H), 5.82-5.91 
(m, 1 H), 7.33-7.46 (m, 5 H).  
13C NMR (100 MHz, CD3OD): δ (ppm) 21.14, 63.94, 68.34, 68.82, 69.74, 70.83, 76.17, 
99.57, 101.93, 118.03, 126.24, 128.30, 129.13, 133.40, 137.27, 170.18. 
MS (ESI): 373 (M+Na)+ 
 
OOO
Ph
AcO
O
OH
OHO
AcO
O
OPivHO
 
 
Synthesis of Allyl-3-O-acetyl-4,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside 
Allyl-3-O-acetyl-4,6-O-benzylidene-2-hydroxy-α-D-mannopyranoside (2.24 g, 6.40 mmol) 
was dissolved in dichloromethane (40 mL) at room temperature. DMAP (1.56 g, 12.8 
mmol) was added followed by pivaloyl chloride (0.95 mL, 7.68 mmol) and it was then 
stirred for 1 h. After the reaction was complete, ethyl acetate/hexane (1:3) (60 mL) was 
added. The white solid was filtered over celite and the filtrate was concentrated. A solution 
of crude Allyl-3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-α-D-mannopyranoside in 60% 
aq. AcOH (50 mL) was heated at 70 ºC for 3 h. It was then cooled down to room 
temperature and poured into water (50 mL). The water layer was extracted with ethyl 
acetate (2 x 200 mL). The combined organic layer was washed with sodium bicarbonate (3 
x 80 mL) followed by brine (80 mL) and dried over sodium sulfate. The solvent was 
removed under reduced pressure and the crude product was purified by flash column 
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chromatography on silica gel using 45% ethyl acetate/hexane to yield of the desired 
product (1.81 g, 5.22 mmol, 91%) as white oil. 
Rf 0.15 (silica, 50% EtOAc/hexane) 
1H NMR (400 MHz, CDCl3) δ (ppm) 1.19 (s, 9 H), 2.01 (s, 3 H), 2.18 (br s, 1 H), 2.74 (br 
s, 1 H), 3.69-3.73 (m, 1 H), 3.82-3.88 (m, 2 H), 3.94-4.00 (m, 2 H), 4.16 (dd, 1 H, J = 5 
Hz, 13 Hz), 4.77 (s, 1 H, H-1), 5.16-5.30 (m, 4 H), 5.82-5.92 (m, 1 H). 
13C NMR (100 MHz, CDCl3) δ (ppm) 20.88, 27.11, 39.04, 62.28, 66.42, 68.45, 69.47, 
72.26, 72.39, 96.73, 118.12, 133.26, 171.01, 177.44. 
MS (ESI): 348 (M+H)+ 
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Synthesis of Allyl-3-O-acetyl-6-O-t-butyldiphenylsilyl-4-hydroxy-2-O-pivaloyl-α-D-
mannopyranoside 
Allyl-3-O-acetyl-4,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside (1.47 g, 4.24 mmol) 
was dissolved in dichloromethane (30 mL) and cooled to 0 ºC. Imidazole (433 mg, 6.36 
mmol) was added followed by TBDPSCl (1.10 mL, 4.24 mmol) and the reaction mixture 
was stirred at 0 ºC for 1 h. It was then diluted with ethyl acetate (200 mL) and the organic 
layer washed with water (30 mL), HCl (2N, 30 mL), and brine (30 mL). The solvent was 
removed under reduced pressure and the crude product was purified by flash column 
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chromatography on silica gel using 6% ethyl acetate/dichloromethane to give the desired 
product (2.14 g, 3.66 mmol, 86%) as white oil. 
Rf: 0.55 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3) δ (ppm) 1.16 (s, 9 H), 2.05 (s, 3 H), 2.95 (br s, 1 H), 3.84-
4.17 (m, 4 H), 4.28 (d, 1 H, J = 12 Hz), 4.45 (dd, 1 H, J = 3.6 Hz, 12 Hz), 4.81 (s, 1 H, H-
1), 5.02-5.28 (m, 6 H), 5.79-5.88 (m, 1 H), 7.23-7.30 (m, 5 H). 
13C NMR (100 MHz, CDCl3) δ (ppm) 20.72, 27.01, 38.99, 63.09, 65.52, 68.54, 69.12, 
70.03, 70.68, 75.78, 96.67, 118.11, 128.28, 128.33, 128.57, 128.59, 133.18, 135.00, 
154.52, 171.40, 177.34. 
MS (ESI): 587 (M+H)+ 
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Synthesis of Allyl-3-O-acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-
mannopyranoside 
To a solution of allyl-3-O-acetyl-6-O-t-butyldiphenylsilyl-4-hydroxy-2-O-pivaloyl-α-D-
mannopyranoside (1.67 g, 2.85 mmol) in dichloromethane (20 mL) and cyclohexane (10 
mL) was added benzyltrichloroacetimidate (2.88 g, 11.4 mmol). The reaction mixture was 
cooled to 0 ºC and trfilic acid (0.13 mL, 1.43 mmol) was added. It was then stirred at the 
same temperature for 8 h and filtered over celite. The filtrate was washed with saturated 
sodium bicarbonate (30 mL), water (30 mL), and brine (30 mL), and dried over sodium 
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sulfate. The solvent was removed under reduced pressure and the crude product was 
subjected to the next step without further purification. 
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Synthesis of 3-O-Acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-
mannopyranoside 
The crude allyl-3-O-acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-
mannopyranoside (1.06 g, 1.57 mmol) was dissolved in a mixture of acetic acid (5 mL) 
and water (1 mL) (5:1). Sodium acetate (386 mg, 4.71 mmol) was added followed by 
palladium chloride (416 mg, 2.35 mmol) and the reaction mixture was heated in a 
commercial microwave oven at 100 W power and 80 ºC for 5 min. It was then filtered over 
celite and extracted with ethyl acetate (2 x 50 mL). The combined organic layer was 
washed with sodium bicarbonate (3 x 30 mL) followed by brine (50 mL) and dried over 
sodium sulfate. The solvent was removed under reduced pressure and the crude product 
was purified by flash column chromatography on silica gel using 8% ethyl 
acetate/dichloromethane to give the desired lactol as a mixture of anomers. 
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Synthesis of 3-O-Acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α/β-D-
mannopyranosyl trichloroacetimidate 
To a solution of 3-O-acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-
mannopyranoside (229 mg, 0.360 mmol) in dichloromethane (4 mL) was added powdered 
4 Ǻ molecular sieves (100 mg) and trichloroacetonitrile (0.18 mL, 1.80 mmol) at room 
temperature. The reaction mixture was stirred for 10 min and cesium carbonate (129 mg, 
0.396 mmol) was added and stirred further for 45 min. It was then filtered over celite and 
solvent was removed under reduced pressure. The crude product was directly used for 
glycosylation. 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-2-O-pivaloyl-α-D-mannopyranoside 
A solution of 3-O-acetyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-2-O-pivaloyl-α/β-D-
mannopyranosyl trichloroacetimidate (165 mg, 0.212 mmol) and 3-
(perfluorooctyl)propanyloxybutenyl alcohol (77 mg, 0.141 mmol) in dichloromethane (3 
mL) was cooled to 5 ºC and TMSOTf (13 µL, 0.071 mmol) was added. The reaction 
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mixture was stirred for 15 min. The reaction mixture was quenched with triethylamine (40 
µL) and then concentrated under reduced pressure. The crude product was purified by 
solid-phase extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-
fluorous compounds were eluted with 80% MeOH/water and the desired product was 
eluted by 100% MeOH. The solvent was removed under reduced pressure to obtain 
Fluorous-tagged mannose (151 mg, 0.130 mmol, 92%) as a yellow gel. 
Rf: 0.68 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3) δ (ppm) 1.12 (s, 9 H), 1.26 (s, 9 H), 1.81-1.88 (m, 2 H), 1.93 
(s, 3 H), 2.09-2.20 (m, 2 H), 3.40 (t, 2 H, J = 6 Hz), 3.78-4.18 (m, 7 H), 4.62-4.68 (m, 2 
H), 4.81 (s, 1 H), 5.29 (d, 1 H, J = 1.6 Hz), 5.31-5.37 (m, 1 H), 5.68-5.72 (m, 2 H), 7.16-
7.43 (m, 11 H), 7.73 (d, 2 H, J = 6.8 Hz), 7.77 (d, 2 H, J = 6.4 Hz). 
13C NMR (100 MHz, CDCl3) δ (ppm) 19.40, 20.86, 26.91, 27.16, 39.06, 62.66, 62.81, 
66.56, 68.74, 69.86, 72.26, 72.52, 72.90, 74.96, 77.31, 96.76, 127.67, 127.78, 127.89, 
128.45, 129.73, 129.80, 130.43, 133.13, 133.53, 135.67, 135.94, 138.10, 169.79, 177.60.  
MS (ESI): 1189 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-hydroxy-
2-O-pivaloyl-α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-2-O-pivaloyl-α-D-mannopyranoside (137 mg, 0.118 mmol) in THF (3 
mL) was added acetic acid (30 µL) followed by tetrabutylammonium fluoride (1.0 M in 
THF, 0.24 mL, 0.236 mmol). The reaction mixture was stirred for 10 h and then 
concentrated. The crude product was purified by solid-phase extraction by using a 
Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted 
with 80% MeOH/water and the desired product was eluted by 100% MeOH. The solvent 
was removed under reduced pressure to obtain the desilylated product (89 mg, 0.096 
mmol, 82%) as a white gel. 
Rf: 0.47 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.21 (s, 9 H), 1.81-1.89 (m, 2 H), 1.56 (br s, 1 H), 
1.90 (s, 3 H), 2.06-2.22 (m, 2 H), 3.46 (t, 2 H, J = 6 Hz), 3.73-3.90 (m, 4 H), 4.02 (d, 1 H, 
J = 4.8 Hz), 4.08 (dd, 1 H, J = 6, 13.8 Hz), 4.18 (dd, 1 H, J = 4.4, 12.4 Hz), 4.63 (s, 2 H), 
4.74 (d, 1 H, J = 1.6 Hz), 5.19-5.20 (m, 1 H), 5.31 (dd, 1 H, J = 3.2, 9.6 Hz), 5.62-5.71 (m, 
2 H), 7.23-7.31 (m, 5 H).  
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Synthesis of Allyl-4,6-O-benzylidene-2-hydroxy-3-O-levulinyl-α/β-D-
mannopyranoside 
Allyl-4,6-O-benzylidene-2,3-di-O-hydroxy-α/β-D-mannopyranoside (1.06 g, 3.44 mmol) 
was dissolved in dichloromethane (20 mL) and cooled to –15 ºC and DCC (779 mg, 3.78 
mmol) was added followed by DMAP (84 mg, 0.688 mmol). Levulinic acid (0.39 mL, 3.78 
mmol) was then added dropwise. The reaction mixture was stirred at –15 ºC for 1 h and 
filtered through celite. The filtrate was concentrated and the crude product was taken 
directly to the next step without further purification. 
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Synthesis of Allyl-4,6-O-benzylidene-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside 
Allyl-4,6-O-benzylidene-2-O-hydroxy-3-O-levunilyl-α/β-D-mannopyranoside (1.0 g, 2.46 
mmol) was dissolved in dichloromethane (20 mL) at room temperature. DMAP (600 mg, 
4.92 mmol) was added followed by pivaloyl chloride (0.36 mL, 2.95 mmol) and it was 
then stirred for 1 h. After the reaction was complete, ethyl acetate/hexane (1:3) (60 mL) 
was added. The white solid was filtered over celite and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel using 26% ethyl 
acetate/hexane to give the desired product as α-anomer (635 mg, 1.29 mmol, 53%). 
Rf: 0.72 (EtOAc/hexane, 1:1) 
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1H NMR (400 MHz, CDCl3) δ (ppm) 1.24 (s, 9 H), 2.06 (s, 3 H), 2.38-2.66 (m, 4 H), 3.73-
3.81 (m, 1 H), 3.93-3.98 (m, 3 H), 4.12-4.25 (m, 2 H), 4.75 (d, 1 H, J = 1.2 Hz, H-1), 5.16 
(dd, 1 H, J = 1.2 Hz, 10 Hz), 5.24-5.40 (m, 3 H), 5.54 (s, 1H), 5.81-5.88 (m, 1 H), 7.23-
7.44 (m, 5 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 27.19, 27.85, 29.82, 37.87, 39.03, 63.85, 68.49, 
68.83, 68.88, 69.80, 76.58, 97.66, 101.87, 118.12, 126.24, 128.25, 129.10, 133.17, 137.13, 
171.70, 177.34, 206.24. 
MS (ESI): 513 (M+Na)+ 
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Synthesis of Allyl-4,6-dihydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside 
A solution of allyl-4,6-O-benzylidene-3-O-levunilyl-2-O-pivaloyl-α-D-mannopyranoside 
(635 mg, 1.29 mmol) in 60% aq. AcOH (20 mL) was heated at 70 ºC for 2 h. It was then 
cooled down to room temperature and poured into water (20 mL). The water layer was 
extracted with ethyl acetate (2 x 100 mL). The combined organic layer was washed with 
sodium bicarbonate (3 x 50 mL) followed by brine (50 mL) and dried over sodium sulfate. 
The solvent was removed under reduced pressure and the crude product was purified by 
flash column chromatography on silica gel using 45% ethyl acetate/hexane to yield of the 
desired product (505 mg, 1.25 mmol, 97%) as white oil. 
Rf: 0.22 (EtOAc/hexane, 1:1) 
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1H NMR (400 MHz, CDCl3) δ (ppm) 1.14 (s, 9 H), 2.07 (s, 3 H), 2.30-2.73 (m, 4 H), 3.62-
3.92 (m, 5 H), 4.10 (dd, 1 H, J = 4.4 Hz, 13 Hz), 4.69 (s, 1 H, H-1), 5.06-5.21 (m, 4 H), 
5.71-5.80 (m, 1 H).  
13C NMR (100 MHz, CDCl3) δ (ppm) 27.05, 27.87, 29.79, 37.99, 38.94, 62.14, 66.00, 
68.18, 69.49, 72.28, 72.41, 96.64, 117.83, 133.30, 172.30, 177.43, 207.72. 
MS (ESI): 403 (M+H)+ 
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Synthesis of Allyl-6-O-t-butyldiphenylsilyl-4-hydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside 
Allyl-4,6-dihydroxy-3-O-levunilyl-2-O-pivaloyl-α-D-mannopyranoside (505 mg, 1.25 
mmol) was dissolved in dichloromethane (8 mL) and cooled to 0 ºC. Imidazole (128 mg, 
1.88 mmol) was added followed by TBDPSCl (0.35 mL, 1.38 mmol) and the reaction 
mixture was stirred at 0 ºC for 1 h. It was then diluted with ethyl acetate (100 mL) and the 
organic layer washed with water (30 mL), HCl (2N, 30 mL), and brine (30 mL). The 
solvent was removed under reduced pressure and the crude product was purified by flash 
column chromatography on silica gel using 6% ethyl acetate/dichloromethane to give the 
desired product (700 mg, 1.09 mmol, 87%) as white oil. 
Rf: 0.52 (EtOAc/DCM, 1:9) 
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1H NMR (400 MHz, CDCl3) δ (ppm) 1.07 (s, 9 H), 1.21 (s, 9 H), 2.11 (s, 3 H), 2.40-2.84 
(m, 4 H), 3.16 (d, 1 H, J = 4 Hz), 3.75-3.77 (m, 1 H), 3.93-4.13 (m, 5 H), 4.81 (s, 1 H), 
5.13 (d, 1 H, J = 10 Hz), 5.21-5.26 (m, 3 H), 5.79-5.85 (m, 1 H), 7.33-7.38 (m, 6 H), 7.72 
(d, 4 H, J = 7 Hz). 
13C NMR (100 MHz, CDCl3) δ (ppm) 19.38, 26.91, 27.18, 28.04, 29.81, 38.11, 39.02, 
63.72, 66.34, 67.98, 69.61, 72.57, 72.83, 96.65, 117.76, 127.76, 129.80, 133.29, 133.35, 
133.53, 135.71, 135.76, 172.38, 177.56, 207.36. 
MS (ESI): 643 (M+H)+ 
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Synthesis of Allyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-
D-mannopyranoside 
To a solution of allyl-6-O-t-butyldiphenylsilyl-4-hydroxy-3-O-levunilyl-2-O-pivaloyl-α-D-
mannopyranoside (1.69 g, 2.63 mmol) in dichloromethane (20 mL) and cyclohexane (10 
mL) was added benzyltrichloroacetimidate (2.0 g, 7.89 mmol). The reaction mixture was 
cooled to 0 ºC and trfilic acid (0.12 mL, 1.32 mmol) was added. It was then stirred at the 
same temperature for 6 h and filtered over celite. The filtrate was washed with saturated 
sodium bicarbonate (30 mL), water (30 mL), and brine (30 mL), and dried over sodium 
sulfate. The solvent was removed under reduced pressure and the crude product was 
subjected to the next step without further purification. 
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Synthesis of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α/β-D-
mannopyranoside 
To crude allyl-4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levunilyl-2-O-pivaloyl-α-D-
mannopyranoside (2.50 g, 3.42 mmol) in methanol (30 mL) was added palladium chloride 
(303 mg, 1.71 mmol). The reaction mixture was stirred for 2 h at room temperature and 
filtered over celite. The solvent was removed under reduced pressure and the crude product 
was purified by flash column chromatography on silica gel using 8% ethyl 
acetate/dichloromethane to the desired product as a mixture of anomers (1.94 g, 3.37 
mmol, 85%). 
Rf: 0.32 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.09 (s, 9 H), 1.26 (s, 9 H), 2.13 (s, 3 H), 2.32-2.49 
(m, 2 H), 2.61-2.78 (m, 2 H), 3.05 (d, 1 H, J = 4 Hz), 3.81-4.19 (m, 4H), 4.60-4.73 (m, 
2H), 5.12 (s, 1H), 5.24 (s, 1H), 5.36-5.41 (m, 1H), 7.16-7.38 (m, 11H), 7.67-7.74 (m, 4H). 
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Synthesis of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α/β-D-
mannopyranosyl trichloroacetimidate 
To a solution of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levunilyl-2-O-pivaloyl-α/β-D-
mannopyranoside (735 mg, 1.06 mmol) in dichloromethane (8 mL) was added powdered 4 
Ǻ molecular sieves (200 mg) and trichloroacetonitrile (0.53 mL, 5.30 mmol) at room 
temperature. The reaction mixture was stirred for 10 min and cesium carbonate (380 mg, 
1.17 mmol) was added and stirred further for 45 min. It was then filtered over celite and 
solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography on silica gel using 3% ethyl acetate/dichloromethane to yield the 
desired product (851 mg, 1.02 mmol, 96%)as a mixture of anomers. 
Rf: 0.75 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.14 (s, 9H), 1.30 (s, 9H), 2.17 (s, 3H), 2.40-2.46 
(m, 1H), 2.51-2.58 (m, 1H), 2.64-2.72 (m, 1H), 2.76-2.83 (m, 1H), 3.96-4.06 (m, 3H), 4.30 
(t, 1H, J = 10 Hz), 4.69 (d, 1H, J = 10.8 Hz), 4.79 (d, 1H, J = 11.2 Hz), 5.47 (dd, 1H, J = 
3.6, 10 Hz), 5.50-5.52 (m, 1H), 6.32 (s, 1H), 7.23-7.45 (m, 11H), 7.72-7.76 (m, 4H), 8.71 
(s, 1H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 19.45, 27.02, 27.24, 27.82, 29.89, 37.87, 39.13, 
62.35, 68.13, 72.07, 72.30, 75.04, 75.18, 90.89, 95.41, 127.77, 127.85, 127.96, 128.14, 
128.52, 129.81, 129.87, 132.95, 133.51, 135.73, 135.97, 137.88, 160.11, 171.80, 177.34, 
206.19. 
MS (ESI): 837 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside 
A solution of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levunilyl-2-O-pivaloyl-α/β-D-
mannopyranosyl trichloroacetimidate (200 mg, 0.239 mmol) and 3-
(perfluorooctyl)propanyloxybutenyl alcohol (87 mg, 0.159 mmol) in dichloromethane (3 
mL) was cooled to 5 ºC and TMSOTf (15 µL, 0.80 mmol) was added. The reaction mixture 
was stirred for 15 min. The reaction mixture was quenched with triethylamine (30 µL) and 
then concentrated under reduced pressure. The crude product was purified by solid-phase 
extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to obtain Fluorous-tagged 
mannose (183 mg, 0.150 mmol, 95%) as a yellow gel. 
Rf: 0.71 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.10 (s, 9 H), 1.24 (s, 9 H), 1.77-1.86 (m, 2 H), 
2.05-2.21 (m, 2 H), 2.15 (s, 3 H), 2.32-2.49 (m, 2 H), 2.61-2.78 (m, 2 H), 3.38 (t, 2 H, J = 
6 Hz), 3.77 (d, 1 H, J = 9.6 Hz), 3.88-4.17 (m, 7 H), 4.61 (d, 1 H, J = 11.2 Hz), 4.70 (d, 1 
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H, J = 11.2 Hz), 4.79 (s, 1 H), 5.24 (s, 1 H), 5.35 (dd, 1 H, J = 3.2, 9.6 Hz), 5.61-5.71 (m, 2 
H), 7.17-7.43 (m, 11 H), 7.73 (dd, 4 H, J = 6.8, 14.8 Hz). 
13C NMR (100 MHz, CDCl3): δ (ppm) 19.37, 20.84, 26.90, 27.15, 27.89, 29.82, 37.86, 
39.04, 62.65, 62.82, 66.53, 68.72, 69.81, 72.54, 72.65, 72.76, 74.93, 96.74, 127.64, 127.76, 
127.87, 127.92, 128.41, 129.70, 129.77, 130.40, 133.15, 133.52, 135.66, 135.91, 138.05, 
171.76, 177.65, 206.32.  
MS (ESI): 1223 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-hydroxy-3-O-
levulinyl-2-O-pivaloyl-α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-3-O-levunilyl-2-O-pivaloyl-α-D-mannopyranoside (102 mg, 0.084 
mmol) in THF (3 mL) was added acetic acid (30 µL) followed by tetrabutylammonium 
fluoride (1.0 M in THF, 0.17 mL, 0.168 mmol). The reaction mixture was stirred for 8 h 
and then concentrated. The crude product was purified by solid-phase extraction by using a 
Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted 
with 80% MeOH/water and the desired product was eluted by 100% MeOH. The solvent 
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was removed under reduced pressure to obtain the desilylated product (57 mg, 0.058 
mmol, 70%) as a yellow gel. 
Rf: 0.54 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.20 (s, 9 H), 1.80-1.88 (m, 2 H), 2.07-2.21 (m, 2 
H), 2.13 (s, 3 H), 2.32-2.49 (m, 2 H), 2.61-2.78 (m, 2 H), 3.45 (t, 2 H, J = 6 Hz), 3.72-3.83 
(m, 3 H), 3.90 (t, 1 H, 9.6 Hz), 4.01 (d, 2 H, J = 5.2 Hz), 4.07 (dd, 1 H, J = 6.4, 12.8 Hz), 
4.17 (dd, 1 H, J = 5.6, 13.2 Hz), 5.17 (dd, 1 H, J = 2, 3.2 Hz), 5.33 (dd, 1 H, J = 3.2, 10 
Hz), 5.63-5.71 (m, 2 H), 7.23-7.34 (m, 5 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.82, 27.11, 27.85, 29.84, 37.81, 39.02, 61.78, 
63.16, 66.51, 68.86, 69.62, 71.95, 72.24, 72.35, 74.91, 96.90, 127.89, 128.02, 128.22, 
128.51, 130.19, 137.76, 171.73, 177.42, 206.31. 
MS (ESI): 983 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-dihydroxy-2-O-
pivaloyl-α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-hydroxy-3-O-
levunilyl-2-O-pivaloyl-α-D-mannopyranoside (42 mg, 0.043 mmol) in pyridine (3 mL) 
was added 1 M solution of NH2NH2.H2O in pyridine/acetic acid (3:2) (0.215 mmol, 0.22 
121
mL). The reaction mixture was stirred for 30 min and then concentrated. The crude product 
was purified by solid-phase extraction by using a Fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
obtain the desired product (36 mg, 0.041 mmol, 95%) as a yellow gel. 
Rf: 0.38 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.21 (s, 9 H), 1.62 (br s, 1 H), 1.81-1.88 (m, 4 H), 
2.09-2.18 (m, 2 H), 3.39 (br s, 1 H), 3.45 (t, 2 H, J = 6 Hz), 3.64-3.72 (m, 2 H), 3.76 (dd, 1 
H, J = 3.6, 12 Hz), 3.84 (dd, 1 H, J = 2.4, 12 Hz), 4.00 (d, 1 H, J = 5.6 Hz), 4.05 (dd, 1 H, 
J = 6, 12.8 Hz), 4.11-4.19 (m, 2 H), 4.70 (d, 1 H, J = 11.2 Hz), 4.75 (d, 1 H, J = 1.2 Hz), 
4.77 (d, 1 H, J = 11.2 Hz), 5.02-5.04 (m, 1 H), 5.62-5.73 (m, 2 H), 7.23-7.33 (m, 5 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 27.15, 39.11, 62.01, 63.15, 66.49, 68.88, 70.46, 
71.77, 72.08, 74.99, 75.15, 96.96, 128.03, 128.18, 128.31, 128.34, 128.68, 130.08, 137.98, 
178.11. 
MS (ESI): 884 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-di-O-(2-O-acetyl-
3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside 
 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-dihydroxy-2-O-
pivaloyl-α-D-mannopyranoside (30 mg, 0.034 mmol) and 2-O-acetyl-3,4,6-O-tribenzyl-
α/β-D-mannopyranosyl trichloroacetimidate (65 mg, 0.102 mmol) in dichloromethane (3 
mL) was cooled to 5 ºC and TMSOTf (15 µL, 0.80 mmol) was added. The reaction mixture 
was stirred for 30 min. The reaction mixture was quenched with triethylamine (30 µL) and 
then concentrated under reduced pressure. The crude product was purified by solid-phase 
extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to obtain mannose 
trisaccharide (58 mg, 0.032 mmol, 94%) as a yellow gel. 
Rf: 0.78 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.17 (s, 9 H), 1.78-1.85 (m, 2 H), 2.09 (s, 3 H), 2.13 
(s, 3 H), 2.08-2.18 (m, 2 H), 3.41 (t, 2 H, J = 6 Hz), 3.57-4.18 (m, 18 H), 4.40-4.49 (m, 7 
H), 4.59-4.73 (m, 7 H), 4.83 (d, 2 H, J = 10.8 Hz), 4.96 (s, 1 H), 5.04 (s, 1 H), 5.13 (s, 1 
H), 5.35 (s, 1 H), 5.44 (d, 1 H, J = 2 Hz), 5.56-5.68 (m, 2 H), 7.10-7.38 (m, 35 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.86, 21.10, 21.15, 27.20, 39.01, 63.18, 65.88, 
66.52, 68.21, 68.40, 68.61, 68.79, 70.84, 71.69, 71.77, 71.82, 71.95, 72.12, 73.41, 73.47, 
73.95, 74.16, 74.50, 74.62, 77.29, 77.59, 78.06, 78.57, 96.37, 98.29, 100.22, 127.27, 
127.29, 127.32, 127.51, 127.60, 127.68, 127.72, 127.79, 127.87, 127.90, 127.96, 128.07, 
123
128.13, 128.17, 128.27, 128.35, 128.36, 128.39, 128.51, 128.57, 130.11, 137.59, 137.75, 
137.83, 138.11, 138.36, 138.38, 138.84, 170.27, 170.30, 177.57. 
MS (ESI): 1835 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-3,6-di-O-(α-D-mannopyranosyl)-
α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-di-O-(2-O-acetyl-
3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside (120 mg, 
0.066 mmol) in methanol (4 mL) was added 0.5 M NaOMe (0.26 mL, 0.132 mmol) and the 
reaction mixture was stirred at ambient temperature for 48 h. The crude product was 
purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide deacetylated mannose (109 mg, 0.066 mmol, 86%) as yellow oil. To a solution of 
3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-O-acetyl-3,4,6-tri-O-
benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside (109 mg, 0.066 mmol) in methanol 
(3 mL) was added 10% Pd/C (50 mg). The reaction mixture was stirred at ambient 
temperature under hydrogen atmosphere for 30 h. The reaction mixture was then filtered 
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over Celite and the solvent was removed under reduced pressure to provide (63 mg, 0.061 
mmol, 92%) as a solid. 
Rf:  0.45 (methanol/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.61-1.66 (m, 4 H), 1.79-1.86 (m, 2 H), 2.16-2.28 
(m, 2 H), 3.41-3.51 (m, 6 H), 3.56-3.82 (m, 14 H), 3.90 (dd, 1 H, J = 7, 11.2 Hz), 3.93-3.96 
(m, 1 H), 4.01-4.03 (m, 1 H), 4.62 (s, 1 H), 4.67 (d, 1 H, J = 1.6 Hz), 4.79 (s, 1 H), 5.03 (s, 
1 H). 
13C NMR (100 MHz, CD3OD): δ (ppm) 20.62, 26.27, 27.47, 28.25, 61.49, 65.86, 66.11, 
67.10, 67.20, 67.38, 68.80, 70.09, 70.37, 70.74, 71.09, 71.26, 72.01, 72.99, 73.55, 79.55, 
100.02, 100.38, 102.64.  
MS (ESI): 1037 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-6-O-(4-
O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-
2-O-pivaloyl-α-D-mannopyranoside 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-hydroxy-3-O-levunilyl-
2-O-pivaloyl-α-D-mannopyranoside (78 mg, 0.079 mmol) and 4-O-benzyl-6-O-t-
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butyldiphenylsilyl-3-O-levunilyl-2-O-pivaloyl-α/β-D-mannopyranosyl trichloroacetimidate 
(86 mg, 0.103 mmol) in dichloromethane (3 mL) was cooled to 5 ºC and TMSOTf (7 µL, 
0.40 mmol) was added. The reaction mixture was stirred for 15 min. The reaction mixture 
was quenched with triethylamine (20 µL) and then concentrated under reduced pressure. 
The crude product was purified by solid-phase extraction by using a Fluorous solid-phase 
extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% MeOH/water 
and the desired product was eluted by 100% MeOH. The solvent was removed under 
reduced pressure to obtain mannose disaccharide (118 mg, 0.071 mmol, 90%) as a yellow 
gel. 
Rf: 0.75 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.09 (s, 9 H), 1.19 (s, 9 H), 1,24 (s, 9 H), 1.79-1.86 
(m, 2 H), 2.14 (s, 3 H), 2.16 (s, 3 H), 2.08-2.21 (m, 2 H), 2.37-2.50 (m, 4 H), 2.63-2.76 (m, 
2 H), 3.44 (t, 2 H, J = 6 Hz), 3.70 (d, 2 H, J = 9.6 Hz), 3.81-3.91 (m, 5 H), 4.03-4.21 (m, 5 
H), 4.56 (d, 1 H, J = 11.2 Hz), 4.61 (d, 1 H, J = 11.2 Hz), 4.69 (d, 1 H, J = 2.8 Hz), 4.71 (s, 
2 H), 4.91 (s, 1 H), 5.16 (s, 1 H), 5.31-5.33 (m, 2 H), 5.37 (dd, 1 H, J = 3.6, 10 Hz), 5.56-
5.68 (m, 2 H), 7.10-7.43 (m, 16 H), 7.70 (d, 2 H, J = 6.8 Hz), 7.75 (d, 2 H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3): δ (ppm) 19.37, 26.91, 27.12, 27.17, 27.89, 29.83, 29.86, 
37.83, 37.88, 39.00, 62.60, 63.10, 66.59, 68.76, 69.44, 69.57, 71.09, 72.47, 72.61, 72.67, 
74.76, 74.96, 77.30, 96.68, 98.04, 127.63, 127.75, 127.86, 127.87, 128.38, 128.41, 129.68, 
129.76, 130.53, 133.13, 133.50, 135.69, 135.94, 137.75, 138.14, 171.40, 171.71, 177.38, 
177.65, 206.27. 
MS (ESI): 1679 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-6-O-(4-
O-benzyl-6-hydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-
α-D-mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-6-O-(4-
O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-2-
O-pivaloyl-α-D-mannopyranoside (96 mg, 0.058 mmol) in THF (3 mL) was added acetic 
acid (30 µL) followed by tetrabutylammonium fluoride (1.0 M in THF, 0.17 mL, 0.168 
mmol). The reaction mixture was stirred for 10 h and then concentrated. The crude product 
was purified by solid-phase extraction by using a Fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
obtain the desilylated product (65 mg, 0.046 mmol, 79%) as a yellow gel. 
Rf: 0.54 (EtOAc/DCM, 1:9) 
1H NMR (300 MHz, CDCl3): δ (ppm) 1.20 (s, 9 H), 1,22 (s, 9 H), 1.79-1.86 (m, 3 H), 2.14 
(s, 3 H), 2.16 (s, 3 H), 2.08-2.21 (m, 2 H), 2.36-2.49 (m, 4 H), 2.63-2.74 (m, 2 H), 3.45 (t, 
2 H, J = 6 Hz), 3.68-4.16 (m, 14 H), 4.58 (d, 1 H, J = 11.2 Hz), 4.62 (d, 1 H, J = 11.2 Hz), 
4.69-4.75 (m, 3 H), 4.89 (d, 1 H, J = 2 Hz), 5.15-5.17 (m, 1 H), 5.27-5.38 (m, 3 H), 5.61-
5.72 (m, 2 H), 7.16-7.38 (m, 10 H). 
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13C NMR (75 MHz, CDCl3): δ (ppm) 20.85, 27.12, 27.15, 27.83, 27.88, 29.84, 37.82, 
39.00, 61.61, 63.17, 65.51, 66.56, 68.75, 69.25, 69.53, 71.07, 71.99, 72.07, 72.40, 72.43, 
72.53, 74.81, 74.94, 96.71, 97.89, 127.66, 127.87, 127.98, 128.22, 128.47, 128.49, 130.47, 
137.77, 137.82, 171.39, 171.72, 177.12, 177.61, 206.26, 206.28. 
MS (ESI): 1419 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-hydroxy-6-O-(4-O-
benzyl-3,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-
mannopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-6-O-(4-
O-benzyl-6-hydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-α-
D-mannopyranoside (65 mg, 0.046 mmol) in pyridine (3 mL) was added 1 M solution of 
NH2NH2.H2O in pyridine/acetic acid (3:2) (0.460 mmol, 0.46 mL). The reaction mixture 
was stirred for 30 min and then concentrated. The crude product was purified by solid-
phase extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-
fluorous compounds were eluted with 80% MeOH/water and the desired product was 
eluted by 100% MeOH. The solvent was removed under reduced pressure to obtain the 
desired product (53 mg, 0.043 mmol, 94%) as a yellow gel. 
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Rf: 0.38 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.19 (s, 9 H), 1.21 (s, 9 H), 1.79-2.21 (m, 7 H), 3.44 
(t, 2 H, J = 6 Hz), 3.58-3.86 (m, 9 H), 4.01-4.16 (m, 5 H), 4.62 (d, 1 H, J = 11.2 Hz), 4.69 
(d, 1 H, J = 11.2 Hz), 4.73 (d, 1 H, J = 1.2 Hz), 4.76 (d, 1 H, J = 11.2 Hz), 4.82-4.85 (m, 2 
H), 5.00-5.01 (m, 1 H), 5.08-5.09 (m, 1 H), 5.60-5.69 (m, 2 H), 7.23-7.33 (m, 10 H).  
13C NMR (100 MHz, CDCl3): δ (ppm) 27.13, 27.15, 39.08, 39.13, 61.80, 63.12, 66.11, 
66.52, 68.82, 70.57, 70.72, 70.79, 71.79, 71.85, 72.17, 74.89, 74.91, 74.94, 75.62, 77.28, 
96.68, 97.72, 127.90, 127.95, 128.04, 128.17, 128.29, 128.61, 128.66, 130.18, 138.00, 
138.03, 177.95, 178.27.  
MS (ESI): 1222 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-(2-O-acetyl-3,4,6-
O-tribenzyl-α-D-mannopyranoside)-6-O-[4-O-benzyl-3,6-di-O-(2-O-acetyl-3,4,6-O-
tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside]-2-O-pivaloyl-
α-D-mannopyranoside 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-hydroxy-6-O-(4-O-
benzyl-3,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-
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mannopyranoside (50 mg, 0.041 mmol) and 2-O-acetyl-3,4,6-O-tribenzyl-α/β-D-
mannopyranosyl trichloroacetimidate (117 mg, 0.185 mmol) in dichloromethane (3 mL) 
was cooled to 5 ºC and TMSOTf (4 µL, 0.021 mmol) was added. The reaction mixture was 
stirred for 30 min. The reaction mixture was quenched with triethylamine (30 µL) and then 
concentrated under reduced pressure. The crude product was purified by solid-phase 
extraction by using a Fluorous solid-phase extraction (FSPE) cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to obtain mannose 
pentasaccharide (58 mg, 0.032 mmol, 94%) as a yellow gel. 
Rf: 0.82 (EtOAc/DCM, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.14 (s, 9 H), 1.18 (s, 9 H), 1.79-1.86 (m, 2 H), 2.06 
(s, 3 H), 2.08 (s, 3 H), 2.12 (s, 3 H), 2.03-2.21 (m, 2 H), 3.36 (t, 2 H, J = 6 Hz), 3.53-3.58 
(m, 3 H), 3.59-3.78 (m 12 H), 3.81-3.88 (m, 4 H), 3.90-4.00 (m, 6 H), 4.05-4.12 (m, 2 H), 
4.14 (dd, 1 H, J =3.2, 8.8 Hz), 4.31-4.49 (m, 11 H), 4.52-4.76 (m, 11 H), 4.81-4.86 (m, 3 
H), 4.96 (s, 1 H), 5.03 (s, 1 H), 5.09-5.14 (m, 3 H), 5.34-5.36 (m, 2 H), 5.46 (s, 1 H), 5.58-
5.64 (m, 2 H), 7.09-7.28 (m, 55 H).  
13C NMR (100 MHz, CDCl3): δ (ppm) 20.85, 21.03, 21.07, 21.15, 27.16, 27.23, 29.76, 
38.98, 63.13, 66.53, 68.13, 68.40, 68.55, 68.68, 68.98, 69.02, 70.72, 70.84, 71.24, 71.79, 
71.85, 71.96, 72.13, 72.27, 73.41, 73.48, 73.84, 73.94, 74.11, 74.42, 74.59, 74.82, 75.20, 
75.31, 75.45, 75.52, 77.28, 77.66, 78.19, 78.34, 78.60, 96.24, 97.01, 98.45, 100.17, 100.29, 
127.26, 127.29, 127.49, 127.53, 127.62, 127.65, 127.68, 127.71, 127.75, 127.78, 127.81, 
127.83, 127.86, 127.88, 127.96, 128.01, 128.04, 128.06, 128.09, 128.15, 128.26, 128.33, 
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128.36, 128.44, 128.46, 128.50, 128.53, 128.65, 130.49, 137.48, 137.73, 137.76, 137.82, 
138.10, 138.30, 138.39, 138.89, 138.91, 170.18, 170.24, 177.18, 177.64.  
MS (ESI): 2667 (M+Na)+ 
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Synthesis of 3,4-di-O-benzyl-6,7-dideoxy-1,2-O-(methoxyethylidene)-α-D-hept-6-
enopyranoside 
To a solution of 3,4-di-O-benzyl-6-hydroxy-1,2-O-(methoxyethylidene)-α-D-
mannopyranoside (2.21 g, 5.31 mmol) in dichloromethane was added Dess-Martin reagent 
(4.51 g, 10.6 mmol). The mixture was stirred at room temperature for 30 min before it was 
quenched with aqueous solution of sodium sulfite (10 mL) and sodium bicarbonate (10 
mL). The mixture was further stirred for 15 min and the aqueous layer was extracted with 
dichloromethane (2 x 50 mL). The combined organic layer was dried and concentrated to 
give the crude aldehyde which was taken forward without further purification. To a 
suspension of methyltriphenylphosphonium bromide (2.28 g, 6.37 mmol) in THF was 
cooled to –40 ºC and n-BuLi (2.55 mL, 6.37 mmol, 2.5 M in hexane) was added. The 
reaction mixture was stirred at the same temperature for 30 min and a solution of above 
aldehyde in THF was added. The reaction mixture was further stirred for 1 h. It was then 
allowed to warm up to room temperature over a period of 4 h before it was quenched with 
saturated a solution of ammonium chloride (15 mL) and extracted with ethyl acetate (2 x 
50 mL). The organic layer was washed with water, brine, dried, and concentrated. The 
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crude product was purified by flash column chromatography on silica gel using 22% ethyl 
acetate/hexane to give the desired product (1.38 g, 3.35 mmol, 63%) as a white solid. 
Rf: 0.48 (EtOAc/hexane, 1:9) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.74 (s, 3H), 3.28 (s, 3H), 3.59 (d, 1H, J = 9.2 Hz), 
3.70-3.74 (m, 2H), 4.37-4.38 (m, 1H), 4.66 (d, 1H, J = 10.8 Hz), 4.78 (d, 2H, J = 5.6 Hz), 
4.85 (d, 1H, J = 10.8 Hz), 5.27 (d, 1H, J = 10.8 Hz), 5.34 (d, 1H, J = 2.4 Hz, H-1), 5.43 (d, 
1H, J = 17.2 Hz), 5.93-6.04 (m, 1H), 7.23-7.40 (m, 10H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 24.54, 49.88, 72.61, 74.61, 75.40, 76.85, 78.40, 
78.73, 97.57, 117.86, 123.95, 127.90, 128.08, 128.13, 128.47, 128.60, 134.54, 137.94, 
138.19. 
MS (ESI): 413 (M+H)+ 
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Synthesis of 3,4-di-O-benzyl-(D,L)-glycero-1,2-O-(methoxyethylidene)-α-D-manno-
heptopyranoside 
A solution of 3,4-di-O-benzyl-6,7-dideoxy-1,2-O-(methoxyethylidene)-α-D-hept-6-
enopyranoside (1.38 g, 3.35 mmol) in acetone-water (9:1, 20 mL) was cooled to 0 ºC and 
NMNO (788 mg, 6.70 mmol) was added followed by 2.5 wt% of osmium tetroxide (2.1 
mL, 0.168 mmol) solution. The reaction mixture was stirred at room temperature for 5 h 
and poured into water (30 mL). The aqueous layer was extracted with ethyl acetate (2 x 50 
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mL) and the combined organic layer was dried over sodium sulfate. The solvent was 
removed under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel using 45% ethyl acetate/hexane to give the diol product (1.24 
g, 2.78 mmol, 83%) as a mixture of diasteromers (3:1, by NMR). 
Rf: 0.18 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.68 (s, 3H), 1.71 (s, 1H), 2.45 (br s, 1 H), 2.56 (br 
s, 1 H), 3.26 (s, 3 H), 3.27 (s, 2 H), 3.33-3.45 (m, 3 H), 3.61-4.02 (m, 9 H), 4.38-4.41 (m, 1 
H), 4.66-4.78 (m, 5 H), 4.95-5.02 (m, 1 H), 5.32 (d, 1 H, J = 3.6 Hz), 5.35 (d, 0.5 H, J = 4 
Hz), 7.25-7.41 (m, 15 H). 
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Synthesis of 3,4,6,7-tetra-O-benzyl-1,2-O-(methoxyethylidene)-(D,L)-glycero-α-D-
manno-heptopyranoside 
To a solution of 3,4-di-O-benzyl-(D,L)-glycero-1,2-O-(methoxyethylidene)-α-D-manno-
heptopyranoside (1.24 g, 2.78 mmol) in DMF (10 mL) was added benzyl bromide (0.73 
mL, 6.12 mmol), tetrabutylammonium iodide (205 mg, 0.556 mmol), and sodium hydride 
(334 mg, 8.34 mmol, 60% suspension). The reaction mixture was stirred at room 
temperature for 1 h and then poured into ice-water mixture. The aqueous layer was 
extracted with ethyl acetate (2 x 50 mL) and the combined organic layer was washed with 
water, brine, and dried over sodium sulfate. The solvent was removed under reduced 
pressure and the crude product was purified by flash column chromatography on silica gel 
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using 22% ethyl acetate/hexane to give the desired product (1.26 g, 2.01 mmol, 90%) as a 
gel. 
Rf: 0.52 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.73 (s, 3 H), 1.78 (s, 2 H), 3.30 (s, 3 H), 3.31 (s, 2 
H), 3.28 (s, 3H), 3.41-3.46 (m, 1 H), 3.54 (dd, 1 H, J = 1.6, 9.2 Hz), 3.71-3.84 (m, 5 H), 
3.96-4.15 (m, 4 H), 4.36-4.38 (m, 2 H), 4.49-4.55 (m, 5 H), 4.66-4.88 (m, 9 H), 4.99 (d, 1 
H, J = 10.8 Hz), 5.28 (d, 0.5 H, J = 2.4 Hz), 5.32 (d, 1 H, J = 2.4 Hz), 7.23-7.36 (m, 30 H). 
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Synthesis of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-(D,L)-glycero-α-D-manno-
heptopyranoside 
A solution of 3,4,6,7-tetra-O-benzyl-1,2-O-(methoxyethylidene)-(D,L)-glycero-α-D-
manno-heptopyranoside (140 mg, 0.224 mmol) in 80% aq. AcOH (4 mL) was stirred at 
room temperature for 2 h and poured into ice-water mixture (20 mL). The aqueous layer 
was extracted with ethyl acetate (2 x 40 mL) and the combined organic layer was washed 
with sodium bicarbonate (30 mL), water (20 mL), brine (20 mL), and dried over sodium 
sulfate. The solvent was removed under reduced pressure and the crude product was 
purified by flash column chromatography on silica gel using 28% ethyl acetate/hexane to 
give R (80 mg, 0.131 mmol, 58%) product as single anomer and 32% ethyl acetate/hexane 
to give S product as 1:1 mixture of α:β anomers. (27 mg, 0.045 mmol, 20%). 
134
Compound A 
Rf: 0.39 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 2.11 (s, 3H), 3.68 (dd, 2H, J = 6.8 Hz, 10.8 Hz), 
3.75 (dd, 1H, J = 4.4, 10.4 Hz), 3.85 (t, 1H, J = 9.6 Hz), 4.01-4.05 (m, 1H), 4.15 (d, 1H, J 
= 10 Hz), 4.16 (br s, 1H), 4.45-4.54 (m, 4H), 4.62-4.72 (m, 3H), 4.85 (d, 1H, J = 10.8 Hz), 
5.12 (s, 1H), 5.35-5.36 (m, 1H), 7.15-7.33 (m, 20H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 21.20, 69.12, 70.36, 71.79, 71.92, 72.29, 73.34, 
74.47, 74.77, 78.15, 92.38, 127.58, 127.66, 127.81, 128.06, 128.19, 128.37, 128.39, 
128.42, 128.48, 137.98, 138.20, 138.27, 138.49, 170.49. 
MS (ESI): 613 (M+H)+ 
Compound B 
Rf: 0.33 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 2.12 (s, 3H), 2.14 (s, 3H), 3.66-3.75 (m, 6H), 3.94-
4.09 (m, 6H), 4.29 (d, 1H, J = 11.2 Hz), 4.42-4.88 (m, 16H), 5.17 (s, 1H), 5.35 (s, 1H), 
5.65 (s, 1H), 7.15-7.31 (m, 40H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 21.22, 21.14, 67.11, 68.77, 69.82, 70.56, 71.17, 
71.78, 71.94, 72.63, 73.06, 73.25, 73.33, 73.39, 73.86, 74.66, 74.69, 74.79, 76.47, 76.76, 
78.08, 78.20, 81.48, 92.50, 92.53, 127.48, 127.51, 127.56, 127.60, 127.65, 127.72, 127.79, 
127.83, 127.87, 127.91, 127.93, 127.95, 127.98, 128.07, 128.17, 128.31, 128.36, 128.37, 
127.42, 128.48, 128.67, 137.37, 138.10, 138.32, 138.63, 169.12, 171.58.   
MS (ESI): 613 (M+H)+ 
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Synthesis of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-heptopyranosyl 
trichloroacetimidate 
To a solution of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-heptopyranoside 
(60 mg, 0.098 mmol) in dichloromethane (3 mL) was added powdered 4 Ǻ molecular 
sieves (40 mg) and trichloroacetonitrile (0.05 mL, 0.49 mmol) at room temperature. The 
reaction mixture was stirred for 10 min and cesium carbonate (35 mg, 0.108 mmol) was 
added and stirred further for 45 min. It was then filtered over celite and solvent was 
removed under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel using 24% ethyl acetate/hexane to yield the desired product 
(275 mg, 0.353 mmol, 98 %) as a white gel. 
Rf: 0.62 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 2.15 (s, 3 H), 3.69-3.74 (m, 2 H), 4.04-4.14 (m, 4 
H), 4.47 (d, 1 H, J = 3.2 Hz), 4.56-4.80 (m, 6 H), 4.88 (d, 1 H, J = 10.8 Hz), 5.49 (s, 1 H), 
6.28 (d, 1 H, J = 1.2 Hz), 7.19-7.38 (m, 20 H), 8.68 (s, 1 H).  
13C NMR (100 MHz, CDCl3): δ (ppm) 21.01, 67.33, 70.80, 72.17, 72.79, 73.82, 74.92, 
75.10, 77.81, 78.53, 90.86, 95.15, 127.50, 127.59, 127.75, 128.05, 128.08, 128.32, 128.41, 
128.44, 128.56, 137.48, 138.18, 138.37, 138.77, 160.00, 170.00. 
MS (ESI): 757 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-D-glycero-
α-D-manno-heptopyranoside 
A solution of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-heptopyranosyl 
trichloroacetimidate (73 mg, 0.097 mmol) and 3-(perfluorooctyl)propanyloxybutenyl 
alcohol (44 mg, 0.076 mmol) in dichloromethane (3 mL) was cooled to 5 ºC and TMSOTf 
(3 µL, 0.016 mmol) was added. The reaction mixture was stirred for 15 min. The reaction 
mixture was quenched with triethylamine (10 µL) and then concentrated under reduced 
pressure. The crude product was purified by solid-phase extraction by using a fluorous 
solid-phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% 
MeOH/water and the desired product was eluted by 100% MeOH. To the methanol 
solution of 3-(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6,7-tetra-O-benzyl-D-
glycero-α-D-manno-heptopyranoside was added 0.5 M NaOMe (0.29 mL, 0.146 mmol). 
The reaction mixture was stirred for 30 min and concentrated. The crude product was 
purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
obtain deacetylated heptomannose (77 mg, 0.070 mmol, 96%) as a yellow gel. 
Rf: 0.48 (EtOAc/hexane, 1:1) 
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1H NMR (400 MHz, CDCl3): δ (ppm) 1.76-1.82 (m, 2 H), 2.05-2.18 (m, 2 H), 2.40 (br s, 1 
H), 3.33 (t, 2 H, J = 6 Hz), 3.70 (dd, 1 H, J = 6.4, 10 Hz), 3.76 (dd, 1 H, J = 4.8, 10.4 Hz), 
3.83-4.00 (m, 7 H), 4.07 (dd, 1 H, J = 6.4, 13.2 Hz), 4.16 (dd, 1 H, J = 5.6, 13.2 Hz), 4.47 
(d, 2 H, J = 2.8 Hz), 4.58 (d, 1 H, J = 10.8 Hz), 4.66 (d, 2 H, J = 3.2 Hz), 4.71 (d, 2 H, J = 
4.4 Hz), 4.80 (d, 1 H, J = 10.8 Hz), 4.87 (d, 1 H, J = 1.2 Hz), 5.62-5.69 (m, 2 H), 7.16-7.35 
(m, 20 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 62.41, 66.48, 68.20, 68.68, 70.52, 71.96, 72.04, 
72.54, 73.30, 74.33, 74.89, 77.88, 80.77, 97.96, 127.46, 127.55, 127.61, 127.69, 127.88, 
127.94, 128.04, 128.29, 128.36, 128.42, 128.61, 130.42, 137.83, 138.29, 138.40.  
MS (ESI): 1123 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-D-glycero-α-D-manno-
heptopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-hydroxy-
D-glycero-α-D-manno-heptopyranoside (40 mg, 0.036 mmol) in methanol (2 mL) was 
added 10% Pd/C (10 mg). The reaction mixture was stirred at ambient temperature under 
hydrogen atmosphere for 12 h. The reaction mixture was then filtered over Celite and the 
solvent was removed under reduced pressure to provide fully deprotected fluorous-tagged 
heptomannose (27 mg, 0.036 mmol, 100%) as a white solid. 
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Rf: 0.56 (MeOH/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.61-1.64 (m, 4 H), 1.79-1.86 (m, 2 H), 2.16-2.28 
(m, 2 H), 3.38-3.50 (m, 5 H), 3.56 (dd, 1 H, J = 4, 9.6 Hz), 3.62-3.66 (m, 2 H), 3.72-3.76 
(m, 4 H), 3.88-3.89 (m, 1 H), 4.69 (s, 1 H). 
13C NMR (100 MHz, CD3OD): δ (ppm) 20.50, 25.93, 26.23, 27.46, 62.54, 66.92, 68.66, 
68.71, 70.34, 70.63, 71.35, 72.34, 73.21, 100.13. 
MS (ESI): 765 (M+Na)+ 
OBnO
BnO
OAc
BnO
BnO
OH
OBnO
BnO
OAc
BnO
O
NH
CCl3
BnO
 
Synthesis of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-heptopyranosyl 
trichloroacetimidate 
To a solution of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-
heptopyranoside (20 mg, 0.033 mmol) in dichloromethane (2 mL) was added powdered 4 
Ǻ molecular sieves (10 mg) and trichloroacetonitrile (0.02 mL, 0.163 mmol) at room 
temperature. The reaction mixture was stirred for 10 min and cesium carbonate (12 mg, 
0.036 mmol) was added and stirred further for 45 min. It was then filtered over celite and 
solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography on silica gel using 24% ethyl acetate/hexane to yield the desired 
product (23 mg, 0.030 mmol, 94 %) as a yellow gel. 
Rf: 0.60 (EtOAc/hexane, 1:1) 
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1H NMR (400 MHz, CDCl3): δ 2.12 (s, 3H), 2.17 (s, 3H), 3.62-3.81 (m, 6H), 3.97-4.08 
(m, 6H), 4.47-4.88 (m, 16H), 5.44-5.46 (m, 1H), 5.47-5.49 (m, 1H), 6.25 (d, 1H, J = 1.6 
Hz), 6.29 (s, 1H), 7.16-7.32 (m, 40H), 8.63 (s, 1H), 8.65 (s, 1H).   
MS (ESI): 757 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-L-glycero-
α-D-manno-heptopyranoside 
A solution of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-heptopyranosyl 
trichloroacetimidate (23 mg, 0.030 mmol) and 3-(perfluorooctyl)propanyloxybutenyl 
alcohol (19 mg, 0.025 mmol) in dichloromethane (2 mL) was cooled to 5 ºC and TMSOTf 
(1 µL, 0.005 mmol) was added. The reaction mixture was stirred for 15 min. The reaction 
mixture was quenched with triethylamine (10 µL) and then concentrated under reduced 
pressure. The crude product was purified by solid-phase extraction by using a fluorous 
solid-phase extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% 
MeOH/water and the desired product was eluted by 100% MeOH. To this solution of 3-
(perfluorooctyl)propanyloxybutenyl-2-O-acetyl-3,4,6,7-tetra-O-benzyl-L-glycero-α-D-
manno-heptopyranoside in methanol was added 0.5 M NaOMe (0.13 mL, 0.064 mmol). 
The reaction mixture was stirred for 30 min and concentrated. The crude product was 
purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
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cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
obtain deacetylated heptomannose (33 mg, 0.030 mmol, 94%) as a yellow gel. 
Rf: 0.45 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.76-1.82 (m, 2 H), 2.05-2.18 (m, 3 H), 3.38 (t, 2 H, 
J = 6 Hz), 3.75-3.83 (m, 3 H), 3.89-4.11 (m, 8 H), 4.31 (d, 1 H, J = 11.2 Hz), 4.48-4.51 (m, 
3 H), 4.61 (d, 1 H, J = 11.2 Hz), 4.67 (d, 1 H, J = 11.2 Hz), 4.77 (d, 1 H, J = 12 Hz), 4.83 
(d, 1 H, J = 11.2 Hz), 4.92 (s, 1 H), 5.58-5.68 (m, 2 H), 7.18-7.30 (m, 20 H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 62.55, 66.50, 68.09, 68.76, 69.94, 70.88, 71.76, 
72.87, 73.44, 73.64, 74.73, 80.72, 98.43, 127.57, 127.60, 127.71, 128.00, 128.08, 128.39, 
128.45, 128.59, 130.22, 137.83, 138.04, 138.37, 138.64. 
MS (ESI): 1123 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-L-glycero-α-D-manno-
heptopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-hydroxy-
L-glycero-α-D-manno-heptopyranoside (33 mg, 0.030 mmol) in methanol (2 mL) was 
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added 10% Pd/C (10 mg). The reaction mixture was stirred at ambient temperature under 
hydrogen atmosphere for 12 h. The reaction mixture was then filtered over Celite and the 
solvent was removed under reduced pressure to provide fully deprotected fluorous-tagged 
heptomannose (25 mg, 0.036 mmol, 100%) as a white solid. 
Rf: 0.58 (MeOH/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.61-1.64 (m, 4 H), 1.79-1.86 (m, 2 H), 2.16-2.28 
(m, 2 H), 3.37-3.40 (m, 1 H), 3.43-3.48 (m, 4 H), 3.50-3.81 (m, 7 H), 3.96 (s, 1 H), 4.72 (s, 
1 H). 
13C NMR (100 MHz, CD3OD): δ (ppm) 20.50, 25.95, 26.23, 27.46, 63.10, 66.44, 66.94, 
68.71, 69.28, 70.36, 70.90, 71.26, 71.48, 100.23. 
MS (ESI): 765 (M+Na)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-O-
(3,4,6,7-tetra-O-benzyl-D-glycero-α-D-manno-heptopyranoside)-D-glycero-α-D-
manno-heptopyranoside 
A solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-D-glycero-α-
D-manno-heptopyranoside (20 mg, 0.018 mmol) and 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-
glycero-α-D-manno-heptopyranosyl trichloroacetimidate (16 mg, 0.022 mmol) in 
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dichloromethane (2 mL) was cooled to 5 ºC and TMSOTf (1 µL, 0.004 mmol) was added. 
The reaction mixture was stirred for 15 min. The reaction mixture was quenched with 
triethylamine (10 µL) and then concentrated under reduced pressure. The crude product 
was purified by solid-phase extraction by using a fluorous solid-phase extraction (FSPE) 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. To the methanol solution was added 0.5 M NaOMe 
(0.07 mL, 0.034 mmol). The reaction mixture was stirred for 30 min and concentrated. The 
crude product was purified by solid-phase extraction by using a fluorous solid-phase 
extraction (FSPE) cartridge. Non-fluorous compounds were eluted with 80% MeOH/water 
and the desired product was eluted by 100% MeOH. The solvent was removed under 
reduced pressure to obtain deacetylated disaccharide (27 mg, 0.016 mmol, 96%) as a 
yellow gel.  
Rf: 0.67 (EtOAc/hexane, 1:1) 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.75-1.81 (m, 2 H), 2.04-2.15 (m, 2 H), 3.33 (t, 2 H, 
J = 6 Hz), 3.74-4.15 (m, 19 H), 4.41-4.86 (m, 17 H), 5.58-5.68 (m, 2 H), 7.16-7.34 (m, 40 
H). 
13C NMR (100 MHz, CDCl3): δ (ppm) 20.84, 28.02, 29.76, 62.41, 66.48, 68.19, 68.68, 
70.51, 71.95, 72.03, 72.34, 72.53, 73.29, 74.32, 74.88, 77.87, 80.77, 97.95, 127.46, 127.54, 
127.60, 127.68, 127.82, 127.88, 127.93, 128.04, 128.28, 128.35, 128.39, 128.42, 128.52, 
128.61, 130.41, 137.82, 138.29, 138.40, 138.73. 
MS (ESI): 1653 (M+H)+ 
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Synthesis of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(D-glycero-α-D-manno-
heptopyranosyl)-D-glycero-α-D-manno-heptopyranoside 
To a solution of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-O-
(3,4,6,7-tetra-O-benzyl-D-glycero-α-D-manno-heptopyranosyl)-D-glycero-α-D-manno-
heptopyranoside (27 mg, 0.016 mmol) in methanol (2 mL) was added 10% Pd/C (15 mg). 
The reaction mixture was stirred at ambient temperature under hydrogen atmosphere for 24 
h. The reaction mixture was then filtered over Celite and the solvent was removed under 
reduced pressure to provide fully deprotected fluorous-tagged disaccharide (14 mg, 0.015 
mmol, 96%) as a white solid. 
Rf: 0.44 (MeOH/DCM, 1:1) 
1H NMR (400 MHz, CD3OD): δ (ppm) 1.61-1.64 (m, 4 H), 1.79-1.86 (m, 2 H), 2.16-2.28 
(m, 2 H), 3.37-3.40 (m, 1 H), 3.43-3.48 (m, 4 H), 3.50-3.81 (m, 7 H), 3.96 (s, 1 H), 4.72 (s, 
1 H). 
13C NMR (100 MHz, CD3OD): δ (ppm) 20.50, 25.93, 26.23, 27.45, 62.53, 66.94, 68.65, 
68.72, 70.34, 70.62, 71.33, 72.32, 73.20, 100.12.  
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MS (ESI): 957 (M+Na)+ 
 
Microarray Preparation and Screening (Provided by Dr. Beatrice Collet) 
Formation of carbohydrate microarrays. Flurous-tagged carbohydrate compounds were 
dissolved in MeOH/DMSO/water (40/40/20) and spotted on the fluorinated glass slide 
(Fluorous Technologies, Inc) using robot (Cartesian PixSys 5500 Arrayerand arrayer) at 
30% humidity. The glass slide was dried in a humidifying chamber for 2 h.  
Detection of protein-carbohydrate binding.2,3 FITC-labeled Con A (20 µg/mL) in HEPES 
buffer (pH = 7.5, 10 mM) 1 mM CaCl2, 1 mM MnCl2, 100 mM NaCl, 1% BSA (w/v) was 
used for detection of protein-carbohydrate interactions. For protein incubation, 0.2 mL of 
protein solution was applied to the printed glass slide. The arrays was incubated by using a 
PC500 CoverWell incubation chamber and gently shaken to every 5 min for 30 min. It was 
then washed several times with HEPES buffer containing 0.05% TWEEN-20 until there is 
no water sticking on the slide. It was then dried for 30 min in a dark humidity chamber. 
Glass slide was scanned using fluorescence scanner at 488 nm.  
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Appendix: NMR Spectra 
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Figure 3.1: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-
O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.2: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-(2-
O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.3: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-
O-(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-
mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.4: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-
O-(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-
mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.5: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-
O-(2-O-(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)3,4,6-tri-O-benzyl-α-D-
mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.6: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6-tri-O-benzyl-2-O-[2-
O-(2-O-(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl)3,4,6-tri-O-benzyl-α-D-
mannopyranosyl)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.7: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(α-D-
mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.8: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(α-D-
mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.9: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(α-D-
mannopyranosyl)-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.10: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(α-D-
mannopyranosyl)-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.11: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(2-O-(α-D-
mannopyranosyl)-α-D-mannopyranosyl)-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.12: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-2-O-[2-O-(2-O-(α-D-
mannopyranosyl)-α-D-mannopyranosyl)-α-D-mannopyranosyl]-α-D-mannopyranoside. 
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Figure 3.13: 1H NMR of allyl-3-O-acetyl-4,6-O-benzylidene-2-hydroxy-α-D-
mannopyranoside. 
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Figure 3.14: 13C NMR of allyl-3-O-acetyl-4,6-O-benzylidene-2-hydroxy-α-D-
mannopyranoside. 
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Figure 3.15: 1H NMR of allyl-3-O-acetyl-4,6-dihydroxy-2-O-pivaloyl-α-D-
mannopyranoside. 
 
161
 
 
Figure 3.16: 13C NMR of allyl-3-O-acetyl-4,6-dihydroxy-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.17: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-
O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.18: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-
O-t-butyldiphenylsilyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.19: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3-O-acetyl-4-O-benzyl-6-
hydroxy-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.20: 1H NMR of allyl-4,6-O-benzylidene-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.21: 13C NMR of allyl-4,6-O-benzylidene-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.22: 1H NMR of allyl-4,6-dihydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.23: 13C NMR of allyl-4,6-dihydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.24: 1H NMR of allyl-6-O-t-butyldiphenylsilyl-4-hydroxy-3-O-levulinyl-2-O-
pivaloyl-α-D-mannopyranoside. 
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Figure 3.25: 13C NMR of allyl-6-O-t-butyldiphenylsilyl-4-hydroxy-3-O-levulinyl-2-O-
pivaloyl-α-D-mannopyranoside. 
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Figure 3.26: 1H NMR of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-
α-D-mannopyranoside. 
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Figure 3.27: 1H NMR of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-
α-D-mannopyranosyl trichloroacetimidate. 
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Figure 3.28: 13C NMR of 4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-
pivaloyl-α-D-mannopyranosyl trichloroacetimidate. 
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Figure 3.29: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.30: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-O-t-
butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.31: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-hydroxy-3-
O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.32: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-6-hydroxy-3-
O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.33: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-
dihydroxy-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.34: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-
dihydroxy-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.35: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-di-O-(2-
O-acetyl-3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.36: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3,6-di-O-(2-
O-acetyl-3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside. 
 
 
182
 
Figure 3.37: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-3,6-di-O-(α-D-
mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.38: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-3,6-di-O-(α-D-
mannopyranosyl)-α-D-mannopyranoside. 
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Figure 3.39: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-
6-O-(4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.40: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-
levulinyl-6-O-(4-O-benzyl-6-O-t-butyldiphenylsilyl-3-O-levulinyl-2-O-pivaloyl-α-D-
mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.41: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-levulinyl-
6-O-(4-O-benzyl-6-hydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-2-O-
pivaloyl-α-D-mannopyranoside. 
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Figure 3.42: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-
levulinyl-6-O-(4-O-benzyl-6-hydroxy-3-O-levulinyl-2-O-pivaloyl-α-D-mannopyranoside)-
2-O-pivaloyl-α-D-mannopyranoside. 
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Figure 3.43: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-hydroxy-6-
O-(4-O-benzyl-3,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.44: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-hydroxy-6-
O-(4-O-benzyl-3,6-dihydroxy-2-O-pivaloyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-
mannopyranoside. 
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Figure 3.45: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-(2-O-
acetyl-3,4,6-O-tribenzyl-α-D-mannopyranoside)-6-O-[4-O-benzyl-3,6-di-O-(2-O-acetyl-
3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside]-2-O-
pivaloyl-α-D-mannopyranoside. 
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Figure 3.46: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-4-O-benzyl-3-O-(2-O-
acetyl-3,4,6-O-tribenzyl-α-D-mannopyranoside)-6-O-[4-O-benzyl-3,6-di-O-(2-O-acetyl-
3,4,6-O-tribenzyl-α-D-mannopyranoside)-2-O-pivaloyl-α-D-mannopyranoside]-2-O-
pivaloyl-α-D-mannopyranoside. 
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Figure 3.47: 1H NMR of 3,4-di-O-benzyl-6,7-dideoxy-1,2-O-(methoxyethylidene)-α-D-
hept-6-enopyranoside. 
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Figure 3.48: 13C NMR of 3,4-di-O-benzyl-6,7-dideoxy-1,2-O-(methoxyethylidene)-α-D-
hept-6-enopyranoside. 
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Figure 3.49: 1H NMR of 3,4-di-O-benzyl-(D,L)-glycero-1,2-O-(methoxyethylidene)-α-D-
manno-heptopyranoside. 
 
 
 
 
 
 
195
 
Figure 3.50: 1H NMR of 3,4,6,7-tetra-O-benzyl-1,2-O-(methoxyethylidene)-(D,L)-
glycero-α-D-manno-heptopyranoside. 
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Figure 3.51: 1H NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-
heptopyranoside. 
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Figure 3.52: 13C NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-
heptopyranoside. 
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Figure 3.53: 1H NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-
heptopyranoside. 
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Figure 3.54: 13C NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-
heptopyranoside. 
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Figure 3.55: 1H NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-
heptopyranosyl trichloroacetimidate. 
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Figure 3.56: 13C NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-D-glycero-α-D-manno-
heptopyranosyl trichloroacetimidate. 
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Figure 3.57: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-D-
glycero-α-D-manno-heptopyranoside. 
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Figure 3.58: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-D-
glycero-α-D-manno-heptopyranoside. 
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Figure 3.59: 1H NMR of 3,4,6,7-tetra-O-benzyl-2-O-acetyl-L-glycero-α/β-D-manno-
heptopyranosyl trichloroacetimidate. 
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Figure 3.60: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-L-
glycero-α-D-manno-heptopyranoside. 
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Figure 3.61: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-L-
glycero-α-D-manno-heptopyranoside. 
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Figure 3.62: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-D-glycero-α-D-manno-
heptopyranoside. 
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Figure 3.63: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-D-glycero-α-D-manno-
heptopyranoside. 
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Figure 3.64: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-L-glycero-α-D-manno-
heptopyranoside. 
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Figure 3.65: 1H NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-
O-(3,4,6,7-tetra-O-benzyl-D-glycero-α-D-manno-heptopyranoside)-D-glycero-α-D-
manno-heptopyranoside. 
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Figure 3.66: 13C NMR of 3-(perfluorooctyl)propanyloxybutenyl-3,4,6,7-tetra-O-benzyl-2-
O-(3,4,6,7-tetra-O-benzyl-D-glycero-α-D-manno-heptopyranoside)-D-glycero-α-D-
manno-heptopyranoside. 
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Figure 3.67: 1H NMR of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(D-glycero-α-D-
manno-heptopyranosyl)-D-glycero-α-D-manno-heptopyranoside. 
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Figure 3.68: 13C NMR of 3-(perfluorooctyl)propanyloxybutanyl-2-O-(D-glycero-α-D-
manno-heptopyranosyl)-D-glycero-α-D-manno-heptopyranoside. 
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CONCLUSIONS 
 
The goal of this thesis is to devise an efficient method for the synthesis of oligosaccharides 
to provide a handy solution to a practical problem. This was achieved by using an allyl 
fluorous linker that facilitates the synthesis of oligosaccharides as fluorous-tagged 
compounds can by easily separated by fluorous solid phase extraction columns (FSPE). 
Since the glycosylation reactions are done in solution, it requires only 1.5 equivalent of 
sugar donor for each coupling step. We have also shown that this whole process can be 
automated by synthesizing a linear α-(1→2)-linked mannose tetrasaccharide in a manner to 
mimic automated synthesizer.  
 
A C8F17 tail also allows direct formation of carbohydrate microarrays based on 
noncovalent fluorous-fluorous interactions. This was demonstrated by noncovalent 
immobilization of carbohydrates on fluorous derivatized glass slides. Several 
monosaccharides, and disaccharides were printed on a glass slide and screening of these 
carbohydrates against different lectins demonstrated that the noncovalent fluorous–
fluorous interaction is sufficient to retain not only mono- but also disaccharides. Next, we 
prepared microarrays of mannose oligosaccharides and glycero-D-manno heptoses for the 
following purposes: 1) to test if longer chain mannose oligosaccharides will stick to the 
fluorous-coated glass slide, 2) to check if Con A has affinity towards C-6 modified 
mannose. Microarrays revealed that noncovalent fluorous interactions are strong enough to 
hold longer chain mannose oligosaccharides on to the fluorous-coated glass slide. It was 
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also shown that Con A has affinity for both D-glycero-D-manno heptose and L-glycero-D-
manno heptose. This information will be very useful in understanding the role of these 
heptomannose sugars that are found in the core of LPS of several bacteria. 
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